

Instance: auth-for-164134620f00a6ad7d864c07d28d7b1e
InstanceOf: PPLRegulatedAuthorization
Title: "Regulated Authorization for COPALIA HCTÕhukese polümeerikattega tablett160mg, 12.5mg, 10mg"
Description: "Regulated Authorization for amlodipiin, valsartaan, hüdroklorotiasiid"
Usage: #example
//* id = "" 
//* identifier.system = $spor-prod
* identifier.value = "EU/1/09/575"
//* identifier.use = #official
// Reference to MedicinalProductDefinition:
//MPD
* subject = Reference(mp-164134620f00a6ad7d864c07d28d7b1e)

* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000388 "Republic of Estonia"
* status = $100000072049#100000072099  "Valid"

 
* statusDate = "2009-11-04"
* holder = Reference(ORG-100007373)

Instance: auth-for-04f54f0b120da0e4d613148114948db6
InstanceOf: PPLRegulatedAuthorization
Title: "Regulated Authorization for TENLORISÕhukese polümeerikattega tablett10mg, 50mg"
Description: "Regulated Authorization for amlodipiin, losartaan"
Usage: #example
//* id = "" 
//* identifier.system = $spor-prod
* identifier.value = "837914"
//* identifier.use = #official
// Reference to MedicinalProductDefinition:
//MPD
* subject = Reference(mp-04f54f0b120da0e4d613148114948db6)

* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000388 "Republic of Estonia"
* status = $100000072049#100000072099  "Valid"

 
* statusDate = "2014-02-28"
* holder = Reference(ORG-100000627)

Instance: auth-for-d9b6ef48731c98284badcf0786ddae4a
InstanceOf: PPLRegulatedAuthorization
Title: "Regulated Authorization for TRIVERAM 40MG/10MG/10MGÕhukese polümeerikattega tablett40mg, 10mg"
Description: "Regulated Authorization for amlodipiin, atorvastatiin, perindopriil"
Usage: #example
//* id = "" 
//* identifier.system = $spor-prod
* identifier.value = "885515"
//* identifier.use = #official
// Reference to MedicinalProductDefinition:
//MPD
* subject = Reference(mp-d9b6ef48731c98284badcf0786ddae4a)

* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000388 "Republic of Estonia"
* status = $100000072049#100000072099  "Valid"

 
* statusDate = "2015-09-16"
* holder = Reference(ORG-100000964)

Instance: auth-for-b437fbb92af66ac8602316a292b734a3
InstanceOf: PPLRegulatedAuthorization
Title: "Regulated Authorization for TRIPLIXAMÕhukese polümeerikattega tablett5mg, 1.25mg"
Description: "Regulated Authorization for indapamiid, amlodipiin, perindopriil"
Usage: #example
//* id = "" 
//* identifier.system = $spor-prod
* identifier.value = "835014"
//* identifier.use = #official
// Reference to MedicinalProductDefinition:
//MPD
* subject = Reference(mp-b437fbb92af66ac8602316a292b734a3)

* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000388 "Republic of Estonia"
* status = $100000072049#100000072099  "Valid"

 
* statusDate = "2014-01-27"
* holder = Reference(ORG-100000964)

Instance: auth-for-f561bcd9597099da88e683385eb84d34
InstanceOf: PPLRegulatedAuthorization
Title: "Regulated Authorization for NATRIXAMToimeainet modifitseeritult vabastav tablett10mg, 1.5mg"
Description: "Regulated Authorization for indapamiid, amlodipiin"
Usage: #example
//* id = "" 
//* identifier.system = $spor-prod
* identifier.value = "825213"
//* identifier.use = #official
// Reference to MedicinalProductDefinition:
//MPD
* subject = Reference(mp-f561bcd9597099da88e683385eb84d34)

* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000388 "Republic of Estonia"
* status = $100000072049#100000072099  "Valid"

 
* statusDate = "2013-10-03"
* holder = Reference(ORG-100000964)

Instance: auth-for-c7b7b3ad9b130f95a3ad36a56478ef8c
InstanceOf: PPLRegulatedAuthorization
Title: "Regulated Authorization for COPALIAÕhukese polümeerikattega tablett160mg, 10mg"
Description: "Regulated Authorization for valsartaan, amlodipiin"
Usage: #example
//* id = "" 
//* identifier.system = $spor-prod
* identifier.value = "EU/1/06/372"
//* identifier.use = #official
// Reference to MedicinalProductDefinition:
//MPD
* subject = Reference(mp-c7b7b3ad9b130f95a3ad36a56478ef8c)

* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000388 "Republic of Estonia"
* status = $100000072049#100000072099  "Valid"

 
* statusDate = "2007-01-16"
* holder = Reference(ORG-100007373)

Instance: auth-for-8bcd4c6a63a2a4521739bcbe4ff922e6
InstanceOf: PPLRegulatedAuthorization
Title: "Regulated Authorization for EXFORGE HCTÕhukese polümeerikattega tablett25mg, 160mg, 10mg"
Description: "Regulated Authorization for amlodipiin, valsartaan, hüdroklorotiasiid"
Usage: #example
//* id = "" 
//* identifier.system = $spor-prod
* identifier.value = "EU/1/09/569"
//* identifier.use = #official
// Reference to MedicinalProductDefinition:
//MPD
* subject = Reference(mp-8bcd4c6a63a2a4521739bcbe4ff922e6)

* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000388 "Republic of Estonia"
* status = $100000072049#100000072099  "Valid"

 
* statusDate = "2009-10-16"
* holder = Reference(ORG-100007373)

Instance: auth-for-4f323eeb72eeb1f1fd12be728657ab61
InstanceOf: PPLRegulatedAuthorization
Title: "Regulated Authorization for TWYNSTATablett40mg, 5mg"
Description: "Regulated Authorization for amlodipiin, telmisartaan"
Usage: #example
//* id = "" 
//* identifier.system = $spor-prod
* identifier.value = "EU/1/10/648"
//* identifier.use = #official
// Reference to MedicinalProductDefinition:
//MPD
* subject = Reference(mp-4f323eeb72eeb1f1fd12be728657ab61)

* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000388 "Republic of Estonia"
* status = $100000072049#100000072099  "Valid"

 
* statusDate = "2010-10-07"
* holder = Reference(ORG-100012432)

Instance: auth-for-1679e02bd535d5bf19f330ce4bcf681e
InstanceOf: PPLRegulatedAuthorization
Title: "Regulated Authorization for ALNETATablett5mg"
Description: "Regulated Authorization for amlodipiin"
Usage: #example
//* id = "" 
//* identifier.system = $spor-prod
* identifier.value = "808113"
//* identifier.use = #official
// Reference to MedicinalProductDefinition:
//MPD
* subject = Reference(mp-1679e02bd535d5bf19f330ce4bcf681e)

* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000388 "Republic of Estonia"
* status = $100000072049#100000072099  "Valid"

 
* statusDate = "2013-03-04"
* holder = Reference(ORG-100000627)

Instance: auth-for-4b4b41bca51db4ce2a7ae1853bc6ea85
InstanceOf: PPLRegulatedAuthorization
Title: "Regulated Authorization for AMLODIPINE VITABALANSTablett5mg"
Description: "Regulated Authorization for amlodipiin"
Usage: #example
//* id = "" 
//* identifier.system = $spor-prod
* identifier.value = "744511"
//* identifier.use = #official
// Reference to MedicinalProductDefinition:
//MPD
* subject = Reference(mp-4b4b41bca51db4ce2a7ae1853bc6ea85)

* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000388 "Republic of Estonia"
* status = $100000072049#100000072099  "Valid"

 
* statusDate = "2011-06-10"
* holder = Reference(MO193)

Instance: auth-for-13860393e0d6201d8bced905eab31694
InstanceOf: PPLRegulatedAuthorization
Title: "Regulated Authorization for OLMESARTAN MEDOXOMIL/AMLODIPINE/HYDROCHLOROTHIAZIDE ALEMBICÕhukese polümeerikattega tablett12.5mg, 5mg, 40mg"
Description: "Regulated Authorization for hüdroklorotiasiid, olmesartaanmedoksomiil, amlodipiin"
Usage: #example
//* id = "" 
//* identifier.system = $spor-prod
* identifier.value = "1023521"
//* identifier.use = #official
// Reference to MedicinalProductDefinition:
//MPD
* subject = Reference(mp-13860393e0d6201d8bced905eab31694)

* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000388 "Republic of Estonia"
* status = $100000072049#100000072099  "Valid"

 
* statusDate = "2021-03-03"
* holder = Reference(ORG-100007006)

Instance: auth-for-15a3485fca0150bf08be1d4cb03d6e36
InstanceOf: PPLRegulatedAuthorization
Title: "Regulated Authorization for NORVASCTablett10mg"
Description: "Regulated Authorization for amlodipiin"
Usage: #example
//* id = "" 
//* identifier.system = $spor-prod
* identifier.value = "176397"
//* identifier.use = #official
// Reference to MedicinalProductDefinition:
//MPD
* subject = Reference(mp-15a3485fca0150bf08be1d4cb03d6e36)

* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000388 "Republic of Estonia"
* status = $100000072049#100000072099  "Valid"

 
* statusDate = "1997-08-22"
* holder = Reference(ORG-100023206)

Instance: auth-for-32358d5ad82c1915617c683c151c43b5
InstanceOf: PPLRegulatedAuthorization
Title: "Regulated Authorization for SANORAL HCTÕhukese polümeerikattega tablett25mg, 40mg, 10mg"
Description: "Regulated Authorization for olmesartaanmedoksomiil, amlodipiin, hüdroklorotiasiid"
Usage: #example
//* id = "" 
//* identifier.system = $spor-prod
* identifier.value = "730111"
//* identifier.use = #official
// Reference to MedicinalProductDefinition:
//MPD
* subject = Reference(mp-32358d5ad82c1915617c683c151c43b5)

* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000388 "Republic of Estonia"
* status = $100000072049#100000072099  "Valid"

 
* statusDate = "2011-02-01"
* holder = Reference(ORG-100001429)

Instance: auth-for-7622a96b7cdac59b9ebbffcc7e1a4fa4
InstanceOf: PPLRegulatedAuthorization
Title: "Regulated Authorization for NORVASCTablett5mg"
Description: "Regulated Authorization for amlodipiin"
Usage: #example
//* id = "" 
//* identifier.system = $spor-prod
* identifier.value = "1017220"
//* identifier.use = #official
// Reference to MedicinalProductDefinition:
//MPD
* subject = Reference(mp-7622a96b7cdac59b9ebbffcc7e1a4fa4)

* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000388 "Republic of Estonia"
* status = $100000072049#100000072099  "Valid"

 
* statusDate = "2021-01-06"
* holder = Reference(ORG-100010645)

Instance: auth-for-010be9a91927897698bafa89faddff0f
InstanceOf: PPLRegulatedAuthorization
Title: "Regulated Authorization for WAMLOXÕhukese polümeerikattega tablett5mg, 320mg"
Description: "Regulated Authorization for valsartaan, amlodipiin"
Usage: #example
//* id = "" 
//* identifier.system = $spor-prod
* identifier.value = "979619"
//* identifier.use = #official
// Reference to MedicinalProductDefinition:
//MPD
* subject = Reference(mp-010be9a91927897698bafa89faddff0f)

* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000388 "Republic of Estonia"
* status = $100000072049#100000072099  "Valid"

 
* statusDate = "2019-02-05"
* holder = Reference(ORG-100000627)

Instance: auth-for-b5313c5cbaa184b004949e74d53d9507
InstanceOf: PPLRegulatedAuthorization
Title: "Regulated Authorization for OLSITRIÕhukese polümeerikattega tablett10mg, 40mg, 12.5mg"
Description: "Regulated Authorization for amlodipiin, hüdroklorotiasiid, olmesartaanmedoksomiil"
Usage: #example
//* id = "" 
//* identifier.system = $spor-prod
* identifier.value = "1008020"
//* identifier.use = #official
// Reference to MedicinalProductDefinition:
//MPD
* subject = Reference(mp-b5313c5cbaa184b004949e74d53d9507)

* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000388 "Republic of Estonia"
* status = $100000072049#100000072099  "Valid"

 
* statusDate = "2020-06-25"
* holder = Reference(ORG-100000627)

Instance: auth-for-263ba0af301b3e5c7965d3c03cfc9f36
InstanceOf: PPLRegulatedAuthorization
Title: "Regulated Authorization for SANORAL HCTÕhukese polümeerikattega tablett20mg, 12.5mg, 5mg"
Description: "Regulated Authorization for olmesartaanmedoksomiil, amlodipiin, hüdroklorotiasiid"
Usage: #example
//* id = "" 
//* identifier.system = $spor-prod
* identifier.value = "730411"
//* identifier.use = #official
// Reference to MedicinalProductDefinition:
//MPD
* subject = Reference(mp-263ba0af301b3e5c7965d3c03cfc9f36)

* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000388 "Republic of Estonia"
* status = $100000072049#100000072099  "Valid"

 
* statusDate = "2011-02-01"
* holder = Reference(ORG-100001429)

Instance: auth-for-c6a4d07400af5debe7a409ff078672ac
InstanceOf: PPLRegulatedAuthorization
Title: "Regulated Authorization for VALTRICOMÕhukese polümeerikattega tablett160mg, 5mg, 12.5mg"
Description: "Regulated Authorization for amlodipiin, valsartaan, hüdroklorotiasiid"
Usage: #example
//* id = "" 
//* identifier.system = $spor-prod
* identifier.value = "982419"
//* identifier.use = #official
// Reference to MedicinalProductDefinition:
//MPD
* subject = Reference(mp-c6a4d07400af5debe7a409ff078672ac)

* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000388 "Republic of Estonia"
* status = $100000072049#100000072099  "Valid"

 
* statusDate = "2019-03-05"
* holder = Reference(ORG-100000627)

Instance: auth-for-0626809da44619b0d2c792566acd5a8a
InstanceOf: PPLRegulatedAuthorization
Title: "Regulated Authorization for SANORALÕhukese polümeerikattega tablett10mg, 40mg"
Description: "Regulated Authorization for amlodipiin, olmesartaanmedoksomiil"
Usage: #example
//* id = "" 
//* identifier.system = $spor-prod
* identifier.value = "606308"
//* identifier.use = #official
// Reference to MedicinalProductDefinition:
//MPD
* subject = Reference(mp-0626809da44619b0d2c792566acd5a8a)

* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000388 "Republic of Estonia"
* status = $100000072049#100000072099  "Valid"

 
* statusDate = "2008-10-31"
* holder = Reference(ORG-100001429)

Instance: auth-for-5ce9683130355affc8b16ac3a0a50c7e
InstanceOf: PPLRegulatedAuthorization
Title: "Regulated Authorization for OLSSAÕhukese polümeerikattega tablett20mg, 5mg"
Description: "Regulated Authorization for amlodipiin, olmesartaanmedoksomiil"
Usage: #example
//* id = "" 
//* identifier.system = $spor-prod
* identifier.value = "949617"
//* identifier.use = #official
// Reference to MedicinalProductDefinition:
//MPD
* subject = Reference(mp-5ce9683130355affc8b16ac3a0a50c7e)

* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000388 "Republic of Estonia"
* status = $100000072049#100000072099  "Valid"

 
* statusDate = "2017-09-12"
* holder = Reference(ORG-100000627)

Instance: auth-for-119dda1fbe0cbb4d5766c20a38da5ee0
InstanceOf: PPLRegulatedAuthorization
Title: "Regulated Authorization for OLSITRIÕhukese polümeerikattega tablett10mg, 40mg, 25mg"
Description: "Regulated Authorization for olmesartaanmedoksomiil, hüdroklorotiasiid, amlodipiin"
Usage: #example
//* id = "" 
//* identifier.system = $spor-prod
* identifier.value = "1008120"
//* identifier.use = #official
// Reference to MedicinalProductDefinition:
//MPD
* subject = Reference(mp-119dda1fbe0cbb4d5766c20a38da5ee0)

* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000388 "Republic of Estonia"
* status = $100000072049#100000072099  "Valid"

 
* statusDate = "2020-06-25"
* holder = Reference(ORG-100000627)

Instance: auth-for-d60f852183ec7c722cb53397956b2ae7
InstanceOf: PPLRegulatedAuthorization
Title: "Regulated Authorization for VALTRICOMÕhukese polümeerikattega tablett25mg, 10mg, 160mg"
Description: "Regulated Authorization for valsartaan, hüdroklorotiasiid, amlodipiin"
Usage: #example
//* id = "" 
//* identifier.system = $spor-prod
* identifier.value = "982719"
//* identifier.use = #official
// Reference to MedicinalProductDefinition:
//MPD
* subject = Reference(mp-d60f852183ec7c722cb53397956b2ae7)

* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000388 "Republic of Estonia"
* status = $100000072049#100000072099  "Valid"

 
* statusDate = "2019-03-05"
* holder = Reference(ORG-100000627)

Instance: auth-for-de741236fa2f76511dce73889ad8e0ea
InstanceOf: PPLRegulatedAuthorization
Title: "Regulated Authorization for SANORAL HCTÕhukese polümeerikattega tablett12.5mg, 40mg, 10mg"
Description: "Regulated Authorization for olmesartaanmedoksomiil, amlodipiin, hüdroklorotiasiid"
Usage: #example
//* id = "" 
//* identifier.system = $spor-prod
* identifier.value = "730211"
//* identifier.use = #official
// Reference to MedicinalProductDefinition:
//MPD
* subject = Reference(mp-de741236fa2f76511dce73889ad8e0ea)

* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000388 "Republic of Estonia"
* status = $100000072049#100000072099  "Valid"

 
* statusDate = "2011-02-01"
* holder = Reference(ORG-100001429)

Instance: auth-for-613be9b5571f706096c8eacc2b9907ee
InstanceOf: PPLRegulatedAuthorization
Title: "Regulated Authorization for DAFIROÕhukese polümeerikattega tablett160mg, 5mg"
Description: "Regulated Authorization for valsartaan, amlodipiin"
Usage: #example
//* id = "" 
//* identifier.system = $spor-prod
* identifier.value = "EU/1/06/371"
//* identifier.use = #official
// Reference to MedicinalProductDefinition:
//MPD
* subject = Reference(mp-613be9b5571f706096c8eacc2b9907ee)

* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000388 "Republic of Estonia"
* status = $100000072049#100000072099  "Valid"

 
* statusDate = "2007-01-16"
* holder = Reference(ORG-100007373)

Instance: auth-for-7201bd4cdc4828fe6ce1387234eb80d6
InstanceOf: PPLRegulatedAuthorization
Title: "Regulated Authorization for DAFIRO HCTÕhukese polümeerikattega tablett10mg, 12.5mg, 160mg"
Description: "Regulated Authorization for amlodipiin, valsartaan, hüdroklorotiasiid"
Usage: #example
//* id = "" 
//* identifier.system = $spor-prod
* identifier.value = "EU/1/09/574"
//* identifier.use = #official
// Reference to MedicinalProductDefinition:
//MPD
* subject = Reference(mp-7201bd4cdc4828fe6ce1387234eb80d6)

* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000388 "Republic of Estonia"
* status = $100000072049#100000072099  "Valid"

 
* statusDate = "2009-11-04"
* holder = Reference(ORG-100007373)

Instance: auth-for-accccddd018b8143ee1f6f3ac998ea17
InstanceOf: PPLRegulatedAuthorization
Title: "Regulated Authorization for PRINDALTablett10mg, 4mg, 1.25mg"
Description: "Regulated Authorization for amlodipiin, indapamiid, perindopriil"
Usage: #example
//* id = "" 
//* identifier.system = $spor-prod
* identifier.value = "1040721"
//* identifier.use = #official
// Reference to MedicinalProductDefinition:
//MPD
* subject = Reference(mp-accccddd018b8143ee1f6f3ac998ea17)

* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000388 "Republic of Estonia"
* status = $100000072049#100000072099  "Valid"

 
* statusDate = "2021-09-15"
* holder = Reference(ORG-100004108)

Instance: auth-for-ad5fa36f0a37f7988fe97a35b64703c3
InstanceOf: PPLRegulatedAuthorization
Title: "Regulated Authorization for SANORAL HCTÕhukese polümeerikattega tablett40mg, 25mg, 5mg"
Description: "Regulated Authorization for hüdroklorotiasiid, amlodipiin, olmesartaanmedoksomiil"
Usage: #example
//* id = "" 
//* identifier.system = $spor-prod
* identifier.value = "730511"
//* identifier.use = #official
// Reference to MedicinalProductDefinition:
//MPD
* subject = Reference(mp-ad5fa36f0a37f7988fe97a35b64703c3)

* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000388 "Republic of Estonia"
* status = $100000072049#100000072099  "Valid"

 
* statusDate = "2011-02-01"
* holder = Reference(ORG-100001429)

Instance: auth-for-78d84c5aa9afd2a1393c6c16dc88821e
InstanceOf: PPLRegulatedAuthorization
Title: "Regulated Authorization for PERINDOPRIL/ AMLODIPINE ACTAVISTablett10mg"
Description: "Regulated Authorization for perindopriil, amlodipiin"
Usage: #example
//* id = "" 
//* identifier.system = $spor-prod
* identifier.value = "1040521"
//* identifier.use = #official
// Reference to MedicinalProductDefinition:
//MPD
* subject = Reference(mp-78d84c5aa9afd2a1393c6c16dc88821e)

* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000388 "Republic of Estonia"
* status = $100000072049#100000072099  "Valid"

 
* statusDate = "2021-09-15"
* holder = Reference(ORG-100000064)

Instance: auth-for-c586f4681771f89753c2507e0b94c560
InstanceOf: PPLRegulatedAuthorization
Title: "Regulated Authorization for PERINDOPRIL/AMLODIPINE TEVATablett5mg, 10mg"
Description: "Regulated Authorization for amlodipiin, perindopriil"
Usage: #example
//* id = "" 
//* identifier.system = $spor-prod
* identifier.value = "838614"
//* identifier.use = #official
// Reference to MedicinalProductDefinition:
//MPD
* subject = Reference(mp-c586f4681771f89753c2507e0b94c560)

* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000388 "Republic of Estonia"
* status = $100000072049#100000072099  "Valid"

 
* statusDate = "2014-02-28"
* holder = Reference(ORG-100000229)

Instance: auth-for-9030bbd21e461a4d7993890e64808084
InstanceOf: PPLRegulatedAuthorization
Title: "Regulated Authorization for AMLODIPINE MEDOCHEMIETablett10mg"
Description: "Regulated Authorization for amlodipiin"
Usage: #example
//* id = "" 
//* identifier.system = $spor-prod
* identifier.value = "567207"
//* identifier.use = #official
// Reference to MedicinalProductDefinition:
//MPD
* subject = Reference(mp-9030bbd21e461a4d7993890e64808084)

* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000388 "Republic of Estonia"
* status = $100000072049#100000072099  "Valid"

 
* statusDate = "2007-12-14"
* holder = Reference(MO11501)

Instance: auth-for-ab811c9807131a6fe102e644fd451c1f
InstanceOf: PPLRegulatedAuthorization
Title: "Regulated Authorization for NORVASCTablett5mg"
Description: "Regulated Authorization for amlodipiin"
Usage: #example
//* id = "" 
//* identifier.system = $spor-prod
* identifier.value = "942317"
//* identifier.use = #official
// Reference to MedicinalProductDefinition:
//MPD
* subject = Reference(mp-ab811c9807131a6fe102e644fd451c1f)

* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000388 "Republic of Estonia"
* status = $100000072049#100000072099  "Valid"

 
* statusDate = "2017-06-06"
* holder = Reference(ORG-100009587)

Instance: auth-for-573327ee63325ab95570125a87402104
InstanceOf: PPLRegulatedAuthorization
Title: "Regulated Authorization for ROXAMPEXÕhukese polümeerikattega tablett20mg, 8mg, 5mg"
Description: "Regulated Authorization for rosuvastatiin, amlodipiin, perindopriil"
Usage: #example
//* id = "" 
//* identifier.system = $spor-prod
* identifier.value = "996719"
//* identifier.use = #official
// Reference to MedicinalProductDefinition:
//MPD
* subject = Reference(mp-573327ee63325ab95570125a87402104)

* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000388 "Republic of Estonia"
* status = $100000072049#100000072099  "Valid"

 
* statusDate = "2019-11-04"
* holder = Reference(ORG-100000627)

Instance: auth-for-e83a5f55fb8df6937682eb3505af15a9
InstanceOf: PPLRegulatedAuthorization
Title: "Regulated Authorization for OLMESARTAN MEDOXOMIL/AMLODIPINE ZENTIVAÕhukese polümeerikattega tablett5mg, 40mg"
Description: "Regulated Authorization for olmesartaanmedoksomiil, amlodipiin"
Usage: #example
//* id = "" 
//* identifier.system = $spor-prod
* identifier.value = "954517"
//* identifier.use = #official
// Reference to MedicinalProductDefinition:
//MPD
* subject = Reference(mp-e83a5f55fb8df6937682eb3505af15a9)

* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000388 "Republic of Estonia"
* status = $100000072049#100000072099  "Valid"

 
* statusDate = "2017-11-07"
* holder = Reference(ORG-100004108)

Instance: auth-for-cf354a0807e9cb815fff08cde088fb4a
InstanceOf: PPLRegulatedAuthorization
Title: "Regulated Authorization for FRAMSYLKõvakapsel10mg, 16mg"
Description: "Regulated Authorization for kandesartaan, amlodipiin"
Usage: #example
//* id = "" 
//* identifier.system = $spor-prod
* identifier.value = "915916"
//* identifier.use = #official
// Reference to MedicinalProductDefinition:
//MPD
* subject = Reference(mp-cf354a0807e9cb815fff08cde088fb4a)

* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000388 "Republic of Estonia"
* status = $100000072049#100000072099  "Valid"

 
* statusDate = "2016-09-13"
* holder = Reference(ORG-100002040)

Instance: auth-for-e7d221583fda37b88426e5b3dd80a1b7
InstanceOf: PPLRegulatedAuthorization
Title: "Regulated Authorization for OLSITRIÕhukese polümeerikattega tablett5mg, 20mg, 12.5mg"
Description: "Regulated Authorization for hüdroklorotiasiid, olmesartaanmedoksomiil, amlodipiin"
Usage: #example
//* id = "" 
//* identifier.system = $spor-prod
* identifier.value = "1007720"
//* identifier.use = #official
// Reference to MedicinalProductDefinition:
//MPD
* subject = Reference(mp-e7d221583fda37b88426e5b3dd80a1b7)

* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000388 "Republic of Estonia"
* status = $100000072049#100000072099  "Valid"

 
* statusDate = "2020-06-25"
* holder = Reference(ORG-100000627)

Instance: auth-for-df6f54d028aaf1b44d6e3c437436fe59
InstanceOf: PPLRegulatedAuthorization
Title: "Regulated Authorization for TENLORISÕhukese polümeerikattega tablett100mg, 10mg"
Description: "Regulated Authorization for amlodipiin, losartaan"
Usage: #example
//* id = "" 
//* identifier.system = $spor-prod
* identifier.value = "837714"
//* identifier.use = #official
// Reference to MedicinalProductDefinition:
//MPD
* subject = Reference(mp-df6f54d028aaf1b44d6e3c437436fe59)

* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000388 "Republic of Estonia"
* status = $100000072049#100000072099  "Valid"

 
* statusDate = "2014-02-28"
* holder = Reference(ORG-100000627)

Instance: auth-for-a7d9b11d7516e2c592b590e952fc976a
InstanceOf: PPLRegulatedAuthorization
Title: "Regulated Authorization for NATRIXAMToimeainet modifitseeritult vabastav tablett5mg, 1.5mg"
Description: "Regulated Authorization for amlodipiin, indapamiid"
Usage: #example
//* id = "" 
//* identifier.system = $spor-prod
* identifier.value = "825313"
//* identifier.use = #official
// Reference to MedicinalProductDefinition:
//MPD
* subject = Reference(mp-a7d9b11d7516e2c592b590e952fc976a)

* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000388 "Republic of Estonia"
* status = $100000072049#100000072099  "Valid"

 
* statusDate = "2013-10-03"
* holder = Reference(ORG-100000964)

Instance: auth-for-99095e57e9c62937e8d1830376f48ee1
InstanceOf: PPLRegulatedAuthorization
Title: "Regulated Authorization for TRIVERAM 10MG/5MG/5MGÕhukese polümeerikattega tablett10mg, 5mg"
Description: "Regulated Authorization for perindopriil, atorvastatiin, amlodipiin"
Usage: #example
//* id = "" 
//* identifier.system = $spor-prod
* identifier.value = "885115"
//* identifier.use = #official
// Reference to MedicinalProductDefinition:
//MPD
* subject = Reference(mp-99095e57e9c62937e8d1830376f48ee1)

* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000388 "Republic of Estonia"
* status = $100000072049#100000072099  "Valid"

 
* statusDate = "2015-09-16"
* holder = Reference(ORG-100000964)

Instance: auth-for-6a6e65652a6b7721f4a5f2be70b08b35
InstanceOf: PPLRegulatedAuthorization
Title: "Regulated Authorization for TRIPLIXAMÕhukese polümeerikattega tablett10mg, 2.5mg"
Description: "Regulated Authorization for indapamiid, amlodipiin, perindopriil"
Usage: #example
//* id = "" 
//* identifier.system = $spor-prod
* identifier.value = "835714"
//* identifier.use = #official
// Reference to MedicinalProductDefinition:
//MPD
* subject = Reference(mp-6a6e65652a6b7721f4a5f2be70b08b35)

* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000388 "Republic of Estonia"
* status = $100000072049#100000072099  "Valid"

 
* statusDate = "2014-01-27"
* holder = Reference(ORG-100000964)

Instance: auth-for-da7b63d04b10c63e7a151cb2ba5ff19e
InstanceOf: PPLRegulatedAuthorization
Title: "Regulated Authorization for ZENICAMOTablett16mg, 10mg"
Description: "Regulated Authorization for kandesartaan, amlodipiin"
Usage: #example
//* id = "" 
//* identifier.system = $spor-prod
* identifier.value = "847914"
//* identifier.use = #official
// Reference to MedicinalProductDefinition:
//MPD
* subject = Reference(mp-da7b63d04b10c63e7a151cb2ba5ff19e)

* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000388 "Republic of Estonia"
* status = $100000072049#100000072099  "Valid"

 
* statusDate = "2014-06-27"
* holder = Reference(ORG-100004108)

Instance: auth-for-a1851b4aa535d52d0d2ac4a11fb50172
InstanceOf: PPLRegulatedAuthorization
Title: "Regulated Authorization for AMLODIPINE TEVATablett5mg"
Description: "Regulated Authorization for amlodipiin"
Usage: #example
//* id = "" 
//* identifier.system = $spor-prod
* identifier.value = "589208"
//* identifier.use = #official
// Reference to MedicinalProductDefinition:
//MPD
* subject = Reference(mp-a1851b4aa535d52d0d2ac4a11fb50172)

* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000388 "Republic of Estonia"
* status = $100000072049#100000072099  "Valid"

 
* statusDate = "2008-06-20"
* holder = Reference(ORG-100000229)

Instance: auth-for-b0492c36fe06c5c43abac09862a8849a
InstanceOf: PPLRegulatedAuthorization
Title: "Regulated Authorization for FLUTENSIFToimeainet modifitseeritult vabastav tablett10mg, 1.5mg"
Description: "Regulated Authorization for amlodipiin, indapamiid"
Usage: #example
//* id = "" 
//* identifier.system = $spor-prod
* identifier.value = "824413"
//* identifier.use = #official
// Reference to MedicinalProductDefinition:
//MPD
* subject = Reference(mp-b0492c36fe06c5c43abac09862a8849a)

* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000388 "Republic of Estonia"
* status = $100000072049#100000072099  "Valid"

 
* statusDate = "2013-10-03"
* holder = Reference(ORG-100000964)

Instance: auth-for-7dca549a13b4eb244b56ce4143da701e
InstanceOf: PPLRegulatedAuthorization
Title: "Regulated Authorization for ROXAMPEXÕhukese polümeerikattega tablett5mg, 4mg, 20mg"
Description: "Regulated Authorization for amlodipiin, rosuvastatiin, perindopriil"
Usage: #example
//* id = "" 
//* identifier.system = $spor-prod
* identifier.value = "996619"
//* identifier.use = #official
// Reference to MedicinalProductDefinition:
//MPD
* subject = Reference(mp-7dca549a13b4eb244b56ce4143da701e)

* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000388 "Republic of Estonia"
* status = $100000072049#100000072099  "Valid"

 
* statusDate = "2019-11-04"
* holder = Reference(ORG-100000627)

Instance: auth-for-b180105b4594b1a235b80b581b787e88
InstanceOf: PPLRegulatedAuthorization
Title: "Regulated Authorization for OLMESARTAN MEDOXOMIL/AMLODIPINE/HYDROCHLOROTHIAZIDE ALEMBICÕhukese polümeerikattega tablett10mg, 25mg, 40mg"
Description: "Regulated Authorization for olmesartaanmedoksomiil, hüdroklorotiasiid, amlodipiin"
Usage: #example
//* id = "" 
//* identifier.system = $spor-prod
* identifier.value = "1023821"
//* identifier.use = #official
// Reference to MedicinalProductDefinition:
//MPD
* subject = Reference(mp-b180105b4594b1a235b80b581b787e88)

* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000388 "Republic of Estonia"
* status = $100000072049#100000072099  "Valid"

 
* statusDate = "2021-03-03"
* holder = Reference(ORG-100007006)

Instance: auth-for-a2573215e0763e21fc8a639392996590
InstanceOf: PPLRegulatedAuthorization
Title: "Regulated Authorization for PERINDOPRIL/AMLODIPINE TEVATablett10mg"
Description: "Regulated Authorization for perindopriil, amlodipiin"
Usage: #example
//* id = "" 
//* identifier.system = $spor-prod
* identifier.value = "838414"
//* identifier.use = #official
// Reference to MedicinalProductDefinition:
//MPD
* subject = Reference(mp-a2573215e0763e21fc8a639392996590)

* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000388 "Republic of Estonia"
* status = $100000072049#100000072099  "Valid"

 
* statusDate = "2014-02-28"
* holder = Reference(ORG-100000229)

Instance: auth-for-bb4c6f95eaf1d70ad88821100fa7adf9
InstanceOf: PPLRegulatedAuthorization
Title: "Regulated Authorization for AGEN 10MGTablett10mg"
Description: "Regulated Authorization for amlodipiin"
Usage: #example
//* id = "" 
//* identifier.system = $spor-prod
* identifier.value = "418403"
//* identifier.use = #official
// Reference to MedicinalProductDefinition:
//MPD
* subject = Reference(mp-bb4c6f95eaf1d70ad88821100fa7adf9)

* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000388 "Republic of Estonia"
* status = $100000072049#100000072099  "Valid"

 
* statusDate = "2003-08-08"
* holder = Reference(ORG-100004108)

Instance: auth-for-b0cec8f4f684b9a926520e6574e76d6a
InstanceOf: PPLRegulatedAuthorization
Title: "Regulated Authorization for MIXORTablett80mg, 5mg"
Description: "Regulated Authorization for telmisartaan, amlodipiin"
Usage: #example
//* id = "" 
//* identifier.system = $spor-prod
* identifier.value = "882315"
//* identifier.use = #official
// Reference to MedicinalProductDefinition:
//MPD
* subject = Reference(mp-b0cec8f4f684b9a926520e6574e76d6a)

* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000388 "Republic of Estonia"
* status = $100000072049#100000072099  "Valid"

 
* statusDate = "2015-09-16"
* holder = Reference(ORG-100004108)

Instance: auth-for-9f441068e75d101a49305a458a1bb12c
InstanceOf: PPLRegulatedAuthorization
Title: "Regulated Authorization for PRINDALTablett8mg, 5mg, 2.5mg"
Description: "Regulated Authorization for amlodipiin, perindopriil, indapamiid"
Usage: #example
//* id = "" 
//* identifier.system = $spor-prod
* identifier.value = "1040821"
//* identifier.use = #official
// Reference to MedicinalProductDefinition:
//MPD
* subject = Reference(mp-9f441068e75d101a49305a458a1bb12c)

* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000388 "Republic of Estonia"
* status = $100000072049#100000072099  "Valid"

 
* statusDate = "2021-09-15"
* holder = Reference(ORG-100004108)

Instance: auth-for-15765dbdc2ced1a6cf154b0a0aee9241
InstanceOf: PPLRegulatedAuthorization
Title: "Regulated Authorization for ROXAMPEXÕhukese polümeerikattega tablett8mg, 20mg, 10mg"
Description: "Regulated Authorization for rosuvastatiin, amlodipiin, perindopriil"
Usage: #example
//* id = "" 
//* identifier.system = $spor-prod
* identifier.value = "996819"
//* identifier.use = #official
// Reference to MedicinalProductDefinition:
//MPD
* subject = Reference(mp-15765dbdc2ced1a6cf154b0a0aee9241)

* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000388 "Republic of Estonia"
* status = $100000072049#100000072099  "Valid"

 
* statusDate = "2019-11-04"
* holder = Reference(ORG-100000627)

Instance: auth-for-a3d2de7675556553a5f08e4c88d2c228
InstanceOf: PPLRegulatedAuthorization
Title: "Regulated Authorization for RAMIPRIL/AMLODIPINE SANDOZKõvakapsel10mg"
Description: "Regulated Authorization for amlodipiin, ramipriil"
Usage: #example
//* id = "" 
//* identifier.system = $spor-prod
* identifier.value = "nan"
//* identifier.use = #official
// Reference to MedicinalProductDefinition:
//MPD
* subject = Reference(mp-a3d2de7675556553a5f08e4c88d2c228)

* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000388 "Republic of Estonia"
* status = $100000072049#220000000066  "Pending"

// ERROR[3] - no statusDate INDEX:53
* holder = Reference(ORG-100002040)

Instance: auth-for-45b27b7f250cda110709d2d99ecb83a3
InstanceOf: PPLRegulatedAuthorization
Title: "Regulated Authorization for VALTRICOMÕhukese polümeerikattega tablett160mg, 10mg, 12.5mg"
Description: "Regulated Authorization for hüdroklorotiasiid, amlodipiin, valsartaan"
Usage: #example
//* id = "" 
//* identifier.system = $spor-prod
* identifier.value = "982619"
//* identifier.use = #official
// Reference to MedicinalProductDefinition:
//MPD
* subject = Reference(mp-45b27b7f250cda110709d2d99ecb83a3)

* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000388 "Republic of Estonia"
* status = $100000072049#100000072099  "Valid"

 
* statusDate = "2019-03-05"
* holder = Reference(ORG-100000627)

Instance: auth-for-e1834bf21b77833702defeadd9554a94
InstanceOf: PPLRegulatedAuthorization
Title: "Regulated Authorization for VALTRICOMÕhukese polümeerikattega tablett320mg, 10mg, 25mg"
Description: "Regulated Authorization for amlodipiin, valsartaan, hüdroklorotiasiid"
Usage: #example
//* id = "" 
//* identifier.system = $spor-prod
* identifier.value = "982819"
//* identifier.use = #official
// Reference to MedicinalProductDefinition:
//MPD
* subject = Reference(mp-e1834bf21b77833702defeadd9554a94)

* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000388 "Republic of Estonia"
* status = $100000072049#100000072099  "Valid"

 
* statusDate = "2019-03-05"
* holder = Reference(ORG-100000627)

Instance: auth-for-78ea828e8c2e0f9915b779973ab0c27c
InstanceOf: PPLRegulatedAuthorization
Title: "Regulated Authorization for NORVASCTablett10mg"
Description: "Regulated Authorization for amlodipiin"
Usage: #example
//* id = "" 
//* identifier.system = $spor-prod
* identifier.value = "942417"
//* identifier.use = #official
// Reference to MedicinalProductDefinition:
//MPD
* subject = Reference(mp-78ea828e8c2e0f9915b779973ab0c27c)

* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000388 "Republic of Estonia"
* status = $100000072049#100000072099  "Valid"

 
* statusDate = "2017-06-06"
* holder = Reference(ORG-100009587)

Instance: auth-for-24891bfe3df12ce0ca603528df3819ec
InstanceOf: PPLRegulatedAuthorization
Title: "Regulated Authorization for TRIPLIXAMÕhukese polümeerikattega tablett5mg, 10mg, 2.5mg"
Description: "Regulated Authorization for indapamiid, amlodipiin, perindopriil"
Usage: #example
//* id = "" 
//* identifier.system = $spor-prod
* identifier.value = "835314"
//* identifier.use = #official
// Reference to MedicinalProductDefinition:
//MPD
* subject = Reference(mp-24891bfe3df12ce0ca603528df3819ec)

* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000388 "Republic of Estonia"
* status = $100000072049#100000072099  "Valid"

 
* statusDate = "2014-01-27"
* holder = Reference(ORG-100000964)

Instance: auth-for-6709cadec14d34a4ce70af63e9421a1b
InstanceOf: PPLRegulatedAuthorization
Title: "Regulated Authorization for TRIVERAM 20MG/10MG/10MGÕhukese polümeerikattega tablett20mg, 10mg"
Description: "Regulated Authorization for amlodipiin, perindopriil, atorvastatiin"
Usage: #example
//* id = "" 
//* identifier.system = $spor-prod
* identifier.value = "885215"
//* identifier.use = #official
// Reference to MedicinalProductDefinition:
//MPD
* subject = Reference(mp-6709cadec14d34a4ce70af63e9421a1b)

* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000388 "Republic of Estonia"
* status = $100000072049#100000072099  "Valid"

 
* statusDate = "2015-09-16"
* holder = Reference(ORG-100000964)

Instance: auth-for-fedf52f451906e74f251473ff122a768
InstanceOf: PPLRegulatedAuthorization
Title: "Regulated Authorization for AGEN 5MGTablett5mg"
Description: "Regulated Authorization for amlodipiin"
Usage: #example
//* id = "" 
//* identifier.system = $spor-prod
* identifier.value = "418303"
//* identifier.use = #official
// Reference to MedicinalProductDefinition:
//MPD
* subject = Reference(mp-fedf52f451906e74f251473ff122a768)

* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000388 "Republic of Estonia"
* status = $100000072049#100000072099  "Valid"

 
* statusDate = "2003-08-08"
* holder = Reference(ORG-100004108)

Instance: auth-for-643ee4aafe3a5f6160418089c8bc144f
InstanceOf: PPLRegulatedAuthorization
Title: "Regulated Authorization for PRINDALTablett4mg, 1.25mg, 5mg"
Description: "Regulated Authorization for indapamiid, perindopriil, amlodipiin"
Usage: #example
//* id = "" 
//* identifier.system = $spor-prod
* identifier.value = "1040621"
//* identifier.use = #official
// Reference to MedicinalProductDefinition:
//MPD
* subject = Reference(mp-643ee4aafe3a5f6160418089c8bc144f)

* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000388 "Republic of Estonia"
* status = $100000072049#100000072099  "Valid"

 
* statusDate = "2021-09-15"
* holder = Reference(ORG-100004108)

Instance: auth-for-a10c712d5e22defbadaacf5c590d91c1
InstanceOf: PPLRegulatedAuthorization
Title: "Regulated Authorization for PERINDOPRIL/ AMLODIPINE ACTAVISTablett10mg, 5mg"
Description: "Regulated Authorization for perindopriil, amlodipiin"
Usage: #example
//* id = "" 
//* identifier.system = $spor-prod
* identifier.value = "1040321"
//* identifier.use = #official
// Reference to MedicinalProductDefinition:
//MPD
* subject = Reference(mp-a10c712d5e22defbadaacf5c590d91c1)

* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000388 "Republic of Estonia"
* status = $100000072049#100000072099  "Valid"

 
* statusDate = "2021-09-15"
* holder = Reference(ORG-100000064)

Instance: auth-for-7111a5f4581c96aeb3d849b6c329cd37
InstanceOf: PPLRegulatedAuthorization
Title: "Regulated Authorization for SOBYCOMBITablett10mg"
Description: "Regulated Authorization for bisoprolool, amlodipiin"
Usage: #example
//* id = "" 
//* identifier.system = $spor-prod
* identifier.value = "850514"
//* identifier.use = #official
// Reference to MedicinalProductDefinition:
//MPD
* subject = Reference(mp-7111a5f4581c96aeb3d849b6c329cd37)

* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000388 "Republic of Estonia"
* status = $100000072049#100000072099  "Valid"

 
* statusDate = "2014-09-17"
* holder = Reference(ORG-100000627)

Instance: auth-for-3532848b29b671c8226129387571af81
InstanceOf: PPLRegulatedAuthorization
Title: "Regulated Authorization for CAMDEROTablett16mg, 5mg"
Description: "Regulated Authorization for amlodipiin, kandesartaan"
Usage: #example
//* id = "" 
//* identifier.system = $spor-prod
* identifier.value = "959018"
//* identifier.use = #official
// Reference to MedicinalProductDefinition:
//MPD
* subject = Reference(mp-3532848b29b671c8226129387571af81)

* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000388 "Republic of Estonia"
* status = $100000072049#100000072099  "Valid"

 
* statusDate = "2018-02-13"
* holder = Reference(ORG-100000627)

Instance: auth-for-5196a3ed0766610246524f22c6dfcb0b
InstanceOf: PPLRegulatedAuthorization
Title: "Regulated Authorization for PRINDALTablett10mg, 2.5mg, 8mg"
Description: "Regulated Authorization for indapamiid, perindopriil, amlodipiin"
Usage: #example
//* id = "" 
//* identifier.system = $spor-prod
* identifier.value = "1040921"
//* identifier.use = #official
// Reference to MedicinalProductDefinition:
//MPD
* subject = Reference(mp-5196a3ed0766610246524f22c6dfcb0b)

* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000388 "Republic of Estonia"
* status = $100000072049#100000072099  "Valid"

 
* statusDate = "2021-09-15"
* holder = Reference(ORG-100004108)

Instance: auth-for-e5a5f7e045adf8a26ccfb8c2bf81fd60
InstanceOf: PPLRegulatedAuthorization
Title: "Regulated Authorization for RAMDACORDIA HCTKõvakapsel5mg, 10mg, 25mg"
Description: "Regulated Authorization for amlodipiin, hüdroklorotiasiid, ramipriil"
Usage: #example
//* id = "" 
//* identifier.system = $spor-prod
* identifier.value = "981619"
//* identifier.use = #official
// Reference to MedicinalProductDefinition:
//MPD
* subject = Reference(mp-e5a5f7e045adf8a26ccfb8c2bf81fd60)

* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000388 "Republic of Estonia"
* status = $100000072049#100000072099  "Valid"

 
* statusDate = "2019-03-05"
* holder = Reference(ORG-100002040)

Instance: auth-for-4f29a807fff14bdd583461050ab611da
InstanceOf: PPLRegulatedAuthorization
Title: "Regulated Authorization for AMLODIPINE/VALSARTAN MYLANÕhukese polümeerikattega tablett160mg, 5mg"
Description: "Regulated Authorization for amlodipiin, valsartaan"
Usage: #example
//* id = "" 
//* identifier.system = $spor-prod
* identifier.value = "EU/1/16/1092"
//* identifier.use = #official
// Reference to MedicinalProductDefinition:
//MPD
* subject = Reference(mp-4f29a807fff14bdd583461050ab611da)

* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000388 "Republic of Estonia"
* status = $100000072049#100000072099  "Valid"

 
* statusDate = "2016-03-22"
* holder = Reference(ORG-100034257)

Instance: auth-for-c070bacb375a778ab6acb3e41d9f05be
InstanceOf: PPLRegulatedAuthorization
Title: "Regulated Authorization for OLSITRIÕhukese polümeerikattega tablett12.5mg, 40mg, 5mg"
Description: "Regulated Authorization for olmesartaanmedoksomiil, amlodipiin, hüdroklorotiasiid"
Usage: #example
//* id = "" 
//* identifier.system = $spor-prod
* identifier.value = "1007820"
//* identifier.use = #official
// Reference to MedicinalProductDefinition:
//MPD
* subject = Reference(mp-c070bacb375a778ab6acb3e41d9f05be)

* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000388 "Republic of Estonia"
* status = $100000072049#100000072099  "Valid"

 
* statusDate = "2020-06-25"
* holder = Reference(ORG-100000627)

Instance: auth-for-8ba5ffcc8e6daba03e3877db10902477
InstanceOf: PPLRegulatedAuthorization
Title: "Regulated Authorization for DALNESSATablett4mg, 5mg"
Description: "Regulated Authorization for amlodipiin, perindopriil"
Usage: #example
//* id = "" 
//* identifier.system = $spor-prod
* identifier.value = "802212"
//* identifier.use = #official
// Reference to MedicinalProductDefinition:
//MPD
* subject = Reference(mp-8ba5ffcc8e6daba03e3877db10902477)

* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000388 "Republic of Estonia"
* status = $100000072049#100000072099  "Valid"

 
* statusDate = "2012-11-30"
* holder = Reference(ORG-100000627)

Instance: auth-for-9aaf3b0889d558b5811fdb64d375849b
InstanceOf: PPLRegulatedAuthorization
Title: "Regulated Authorization for OLMESARTAN MEDOXOMIL/AMLODIPINE KRKAÕhukese polümeerikattega tablett40mg, 5mg"
Description: "Regulated Authorization for amlodipiin, olmesartaanmedoksomiil"
Usage: #example
//* id = "" 
//* identifier.system = $spor-prod
* identifier.value = "991219"
//* identifier.use = #official
// Reference to MedicinalProductDefinition:
//MPD
* subject = Reference(mp-9aaf3b0889d558b5811fdb64d375849b)

* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000388 "Republic of Estonia"
* status = $100000072049#100000072099  "Valid"

 
* statusDate = "2019-07-02"
* holder = Reference(ORG-100000627)

Instance: auth-for-0c80dcb4c4e267a27fb81c3d56855721
InstanceOf: PPLRegulatedAuthorization
Title: "Regulated Authorization for TELDIPINTablett5mg, 80mg"
Description: "Regulated Authorization for telmisartaan, amlodipiin"
Usage: #example
//* id = "" 
//* identifier.system = $spor-prod
* identifier.value = "929716"
//* identifier.use = #official
// Reference to MedicinalProductDefinition:
//MPD
* subject = Reference(mp-0c80dcb4c4e267a27fb81c3d56855721)

* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000388 "Republic of Estonia"
* status = $100000072049#100000072099  "Valid"

 
* statusDate = "2017-01-10"
* holder = Reference(ORG-100000627)

Instance: auth-for-94ca8b2b6607663f81de9d9de6f86cc4
InstanceOf: PPLRegulatedAuthorization
Title: "Regulated Authorization for TELMISARTAN/AMLODIPINE ALEMBICTablett80mg, 10mg"
Description: "Regulated Authorization for telmisartaan, amlodipiin"
Usage: #example
//* id = "" 
//* identifier.system = $spor-prod
* identifier.value = "1024421"
//* identifier.use = #official
// Reference to MedicinalProductDefinition:
//MPD
* subject = Reference(mp-94ca8b2b6607663f81de9d9de6f86cc4)

* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000388 "Republic of Estonia"
* status = $100000072049#100000072099  "Valid"

 
* statusDate = "2021-03-03"
* holder = Reference(ORG-100007006)

Instance: auth-for-73a4218f437534c6c8ed0a098a21a879
InstanceOf: PPLRegulatedAuthorization
Title: "Regulated Authorization for EXFORGEÕhukese polümeerikattega tablett10mg, 160mg"
Description: "Regulated Authorization for amlodipiin, valsartaan"
Usage: #example
//* id = "" 
//* identifier.system = $spor-prod
* identifier.value = "EU/1/06/370"
//* identifier.use = #official
// Reference to MedicinalProductDefinition:
//MPD
* subject = Reference(mp-73a4218f437534c6c8ed0a098a21a879)

* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000388 "Republic of Estonia"
* status = $100000072049#100000072099  "Valid"

 
* statusDate = "2007-01-17"
* holder = Reference(ORG-100007373)

Instance: auth-for-2d73f2b40745c9beffb94871f14a5b5a
InstanceOf: PPLRegulatedAuthorization
Title: "Regulated Authorization for DALNESSATablett2.85mg, 2.5mg"
Description: "Regulated Authorization for amlodipiin, perindopriil"
Usage: #example
//* id = "" 
//* identifier.system = $spor-prod
* identifier.value = "969318"
//* identifier.use = #official
// Reference to MedicinalProductDefinition:
//MPD
* subject = Reference(mp-2d73f2b40745c9beffb94871f14a5b5a)

* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000388 "Republic of Estonia"
* status = $100000072049#100000072099  "Valid"

 
* statusDate = "2018-09-11"
* holder = Reference(ORG-100000627)

Instance: auth-for-86425515252bedcd9cee98223732d690
InstanceOf: PPLRegulatedAuthorization
Title: "Regulated Authorization for TRIVERAM 20MG/10MG/5MGÕhukese polümeerikattega tablett5mg, 10mg, 20mg"
Description: "Regulated Authorization for perindopriil, amlodipiin, atorvastatiin"
Usage: #example
//* id = "" 
//* identifier.system = $spor-prod
* identifier.value = "885315"
//* identifier.use = #official
// Reference to MedicinalProductDefinition:
//MPD
* subject = Reference(mp-86425515252bedcd9cee98223732d690)

* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000388 "Republic of Estonia"
* status = $100000072049#100000072099  "Valid"

 
* statusDate = "2015-09-16"
* holder = Reference(ORG-100000964)

Instance: auth-for-9959fedb3a2dfee5867b44aa925ad2ec
InstanceOf: PPLRegulatedAuthorization
Title: "Regulated Authorization for HIPRESTablett5mg"
Description: "Regulated Authorization for amlodipiin"
Usage: #example
//* id = "" 
//* identifier.system = $spor-prod
* identifier.value = "439004"
//* identifier.use = #official
// Reference to MedicinalProductDefinition:
//MPD
* subject = Reference(mp-9959fedb3a2dfee5867b44aa925ad2ec)

* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000388 "Republic of Estonia"
* status = $100000072049#100000072099  "Valid"

 
* statusDate = "2004-03-26"
* holder = Reference(ORG-100000627)

Instance: auth-for-48df8f5cf063ad33bbd7174aaec3f4b2
InstanceOf: PPLRegulatedAuthorization
Title: "Regulated Authorization for TELDIPINTablett80mg, 10mg"
Description: "Regulated Authorization for telmisartaan, amlodipiin"
Usage: #example
//* id = "" 
//* identifier.system = $spor-prod
* identifier.value = "929816"
//* identifier.use = #official
// Reference to MedicinalProductDefinition:
//MPD
* subject = Reference(mp-48df8f5cf063ad33bbd7174aaec3f4b2)

* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000388 "Republic of Estonia"
* status = $100000072049#100000072099  "Valid"

 
* statusDate = "2017-01-10"
* holder = Reference(ORG-100000627)

Instance: auth-for-1d67506966cb02a8f8b5eb63e9d7c12f
InstanceOf: PPLRegulatedAuthorization
Title: "Regulated Authorization for TENLORISÕhukese polümeerikattega tablett5mg, 100mg"
Description: "Regulated Authorization for amlodipiin, losartaan"
Usage: #example
//* id = "" 
//* identifier.system = $spor-prod
* identifier.value = "837614"
//* identifier.use = #official
// Reference to MedicinalProductDefinition:
//MPD
* subject = Reference(mp-1d67506966cb02a8f8b5eb63e9d7c12f)

* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000388 "Republic of Estonia"
* status = $100000072049#100000072099  "Valid"

 
* statusDate = "2014-02-28"
* holder = Reference(ORG-100000627)

Instance: auth-for-7800811ca04d63e52a89c94bc3369489
InstanceOf: PPLRegulatedAuthorization
Title: "Regulated Authorization for COVERAMTablett10mg, 5mg"
Description: "Regulated Authorization for amlodipiin, perindopriil"
Usage: #example
//* id = "" 
//* identifier.system = $spor-prod
* identifier.value = "584308"
//* identifier.use = #official
// Reference to MedicinalProductDefinition:
//MPD
* subject = Reference(mp-7800811ca04d63e52a89c94bc3369489)

* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000388 "Republic of Estonia"
* status = $100000072049#100000072099  "Valid"

 
* statusDate = "2008-05-16"
* holder = Reference(ORG-100000964)

Instance: auth-for-820a0f5b4d1867edcdb92826125560f3
InstanceOf: PPLRegulatedAuthorization
Title: "Regulated Authorization for NORVASCTablett5mg"
Description: "Regulated Authorization for amlodipiin"
Usage: #example
//* id = "" 
//* identifier.system = $spor-prod
* identifier.value = "176297"
//* identifier.use = #official
// Reference to MedicinalProductDefinition:
//MPD
* subject = Reference(mp-820a0f5b4d1867edcdb92826125560f3)

* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000388 "Republic of Estonia"
* status = $100000072049#100000072099  "Valid"

 
* statusDate = "1997-08-22"
* holder = Reference(ORG-100023206)

Instance: auth-for-b8c9a0c3039b6e095804bb4753c0c9a2
InstanceOf: PPLRegulatedAuthorization
Title: "Regulated Authorization for HIPRESTablett10mg"
Description: "Regulated Authorization for amlodipiin"
Usage: #example
//* id = "" 
//* identifier.system = $spor-prod
* identifier.value = "441504"
//* identifier.use = #official
// Reference to MedicinalProductDefinition:
//MPD
* subject = Reference(mp-b8c9a0c3039b6e095804bb4753c0c9a2)

* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000388 "Republic of Estonia"
* status = $100000072049#100000072099  "Valid"

 
* statusDate = "2004-03-26"
* holder = Reference(ORG-100000627)

Instance: auth-for-f4e3bf9b50fac22789ee5d41cd4c5193
InstanceOf: PPLRegulatedAuthorization
Title: "Regulated Authorization for AMLODIPINE /VALSARTAN SANDOZÕhukese polümeerikattega tablett160mg, 5mg"
Description: "Regulated Authorization for valsartaan, amlodipiin"
Usage: #example
//* id = "" 
//* identifier.system = $spor-prod
* identifier.value = "911616"
//* identifier.use = #official
// Reference to MedicinalProductDefinition:
//MPD
* subject = Reference(mp-f4e3bf9b50fac22789ee5d41cd4c5193)

* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000388 "Republic of Estonia"
* status = $100000072049#100000072099  "Valid"

 
* statusDate = "2016-06-07"
* holder = Reference(ORG-100002040)

Instance: auth-for-974541f2156d6f33e2a803fa33453176
InstanceOf: PPLRegulatedAuthorization
Title: "Regulated Authorization for FLUTENSIFToimeainet modifitseeritult vabastav tablett5mg, 1.5mg"
Description: "Regulated Authorization for amlodipiin, indapamiid"
Usage: #example
//* id = "" 
//* identifier.system = $spor-prod
* identifier.value = "824513"
//* identifier.use = #official
// Reference to MedicinalProductDefinition:
//MPD
* subject = Reference(mp-974541f2156d6f33e2a803fa33453176)

* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000388 "Republic of Estonia"
* status = $100000072049#100000072099  "Valid"

 
* statusDate = "2013-10-03"
* holder = Reference(ORG-100000964)

Instance: auth-for-8ecdc31c688fde866ba554202ab24480
InstanceOf: PPLRegulatedAuthorization
Title: "Regulated Authorization for AMLODIGAMMA 10MGTablett10mg"
Description: "Regulated Authorization for amlodipiin"
Usage: #example
//* id = "" 
//* identifier.system = $spor-prod
* identifier.value = "527106"
//* identifier.use = #official
// Reference to MedicinalProductDefinition:
//MPD
* subject = Reference(mp-8ecdc31c688fde866ba554202ab24480)

* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000388 "Republic of Estonia"
* status = $100000072049#100000072099  "Valid"

 
* statusDate = "2006-10-20"
* holder = Reference(ORG-100000454)

Instance: auth-for-f9220c58bd68a6a5525486f4c18ddebc
InstanceOf: PPLRegulatedAuthorization
Title: "Regulated Authorization for TRIVERAM 20MG/5MG/5MGÕhukese polümeerikattega tablett20mg, 5mg"
Description: "Regulated Authorization for atorvastatiin, amlodipiin, perindopriil"
Usage: #example
//* id = "" 
//* identifier.system = $spor-prod
* identifier.value = "885415"
//* identifier.use = #official
// Reference to MedicinalProductDefinition:
//MPD
* subject = Reference(mp-f9220c58bd68a6a5525486f4c18ddebc)

* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000388 "Republic of Estonia"
* status = $100000072049#100000072099  "Valid"

 
* statusDate = "2015-09-16"
* holder = Reference(ORG-100000964)

Instance: auth-for-83c1d9197877904c6c9c2b1ef8d53238
InstanceOf: PPLRegulatedAuthorization
Title: "Regulated Authorization for TENLORISÕhukese polümeerikattega tablett50mg, 5mg"
Description: "Regulated Authorization for losartaan, amlodipiin"
Usage: #example
//* id = "" 
//* identifier.system = $spor-prod
* identifier.value = "837814"
//* identifier.use = #official
// Reference to MedicinalProductDefinition:
//MPD
* subject = Reference(mp-83c1d9197877904c6c9c2b1ef8d53238)

* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000388 "Republic of Estonia"
* status = $100000072049#100000072099  "Valid"

 
* statusDate = "2014-02-28"
* holder = Reference(ORG-100000627)

Instance: auth-for-15ef7c061f169c5ee0d522812fab8e3e
InstanceOf: PPLRegulatedAuthorization
Title: "Regulated Authorization for OLMESARTAN MEDOXOMIL/AMLODIPINE ACCORDÕhukese polümeerikattega tablett20mg, 5mg"
Description: "Regulated Authorization for amlodipiin, olmesartaanmedoksomiil"
Usage: #example
//* id = "" 
//* identifier.system = $spor-prod
* identifier.value = "957217"
//* identifier.use = #official
// Reference to MedicinalProductDefinition:
//MPD
* subject = Reference(mp-15ef7c061f169c5ee0d522812fab8e3e)

* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000388 "Republic of Estonia"
* status = $100000072049#100000072099  "Valid"

 
* statusDate = "2018-01-08"
* holder = Reference(ORG-100003704)

Instance: auth-for-a0a5c6fec3f94cc85dd264a42dc34740
InstanceOf: PPLRegulatedAuthorization
Title: "Regulated Authorization for NORVASCTablett10mg"
Description: "Regulated Authorization for amlodipiin"
Usage: #example
//* id = "" 
//* identifier.system = $spor-prod
* identifier.value = "1017320"
//* identifier.use = #official
// Reference to MedicinalProductDefinition:
//MPD
* subject = Reference(mp-a0a5c6fec3f94cc85dd264a42dc34740)

* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000388 "Republic of Estonia"
* status = $100000072049#100000072099  "Valid"

 
* statusDate = "2021-01-06"
* holder = Reference(ORG-100010645)

Instance: auth-for-89329433313d6f161e047e5039bf430e
InstanceOf: PPLRegulatedAuthorization
Title: "Regulated Authorization for FRAMSYLKõvakapsel5mg, 8mg"
Description: "Regulated Authorization for amlodipiin, kandesartaan"
Usage: #example
//* id = "" 
//* identifier.system = $spor-prod
* identifier.value = "915616"
//* identifier.use = #official
// Reference to MedicinalProductDefinition:
//MPD
* subject = Reference(mp-89329433313d6f161e047e5039bf430e)

* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000388 "Republic of Estonia"
* status = $100000072049#100000072099  "Valid"

 
* statusDate = "2016-09-13"
* holder = Reference(ORG-100002040)

Instance: auth-for-4e3a0f064c251c110dafa89a2b27b36d
InstanceOf: PPLRegulatedAuthorization
Title: "Regulated Authorization for AMLODIPINE /VALSARTAN SANDOZÕhukese polümeerikattega tablett160mg, 10mg"
Description: "Regulated Authorization for valsartaan, amlodipiin"
Usage: #example
//* id = "" 
//* identifier.system = $spor-prod
* identifier.value = "911716"
//* identifier.use = #official
// Reference to MedicinalProductDefinition:
//MPD
* subject = Reference(mp-4e3a0f064c251c110dafa89a2b27b36d)

* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000388 "Republic of Estonia"
* status = $100000072049#100000072099  "Valid"

 
* statusDate = "2016-06-07"
* holder = Reference(ORG-100002040)

Instance: auth-for-6a5b03160e1d68a9d92705962ec17d8e
InstanceOf: PPLRegulatedAuthorization
Title: "Regulated Authorization for GADUARÕhukese polümeerikattega tablett40mg, 12.5mg, 5mg"
Description: "Regulated Authorization for hüdroklorotiasiid, amlodipiin, olmesartaanmedoksomiil"
Usage: #example
//* id = "" 
//* identifier.system = $spor-prod
* identifier.value = "1004520"
//* identifier.use = #official
// Reference to MedicinalProductDefinition:
//MPD
* subject = Reference(mp-6a5b03160e1d68a9d92705962ec17d8e)

* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000388 "Republic of Estonia"
* status = $100000072049#100000072099  "Valid"

 
* statusDate = "2020-04-23"
* holder = Reference(ORG-100004108)

Instance: auth-for-7237aa8d3abcc0e1ce1df7ef512a0eb0
InstanceOf: PPLRegulatedAuthorization
Title: "Regulated Authorization for AMLODIPINE TEVATablett10mg"
Description: "Regulated Authorization for amlodipiin"
Usage: #example
//* id = "" 
//* identifier.system = $spor-prod
* identifier.value = "589308"
//* identifier.use = #official
// Reference to MedicinalProductDefinition:
//MPD
* subject = Reference(mp-7237aa8d3abcc0e1ce1df7ef512a0eb0)

* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000388 "Republic of Estonia"
* status = $100000072049#100000072099  "Valid"

 
* statusDate = "2008-06-20"
* holder = Reference(ORG-100000229)

Instance: auth-for-625cd2885187aca8e4bb01067c8390d4
InstanceOf: PPLRegulatedAuthorization
Title: "Regulated Authorization for OLMESARTAN MEDOXOMIL/AMLODIPINE/HYDROCHLOROTHIAZIDE ALEMBICÕhukese polümeerikattega tablett20mg, 12.5mg, 5mg"
Description: "Regulated Authorization for hüdroklorotiasiid, olmesartaanmedoksomiil, amlodipiin"
Usage: #example
//* id = "" 
//* identifier.system = $spor-prod
* identifier.value = "1023421"
//* identifier.use = #official
// Reference to MedicinalProductDefinition:
//MPD
* subject = Reference(mp-625cd2885187aca8e4bb01067c8390d4)

* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000388 "Republic of Estonia"
* status = $100000072049#100000072099  "Valid"

 
* statusDate = "2021-03-03"
* holder = Reference(ORG-100007006)

Instance: auth-for-94b112c9f717e648a3e1ba8b0b9746eb
InstanceOf: PPLRegulatedAuthorization
Title: "Regulated Authorization for OLMESARTAN MEDOXOMIL/AMLODIPINE/HYDROCHLOROTHIAZIDE ALEMBICÕhukese polümeerikattega tablett40mg, 12.5mg, 10mg"
Description: "Regulated Authorization for hüdroklorotiasiid, amlodipiin, olmesartaanmedoksomiil"
Usage: #example
//* id = "" 
//* identifier.system = $spor-prod
* identifier.value = "1023721"
//* identifier.use = #official
// Reference to MedicinalProductDefinition:
//MPD
* subject = Reference(mp-94b112c9f717e648a3e1ba8b0b9746eb)

* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000388 "Republic of Estonia"
* status = $100000072049#100000072099  "Valid"

 
* statusDate = "2021-03-03"
* holder = Reference(ORG-100007006)

Instance: auth-for-0117d414f0e94ef69e054e81654d62c7
InstanceOf: PPLRegulatedAuthorization
Title: "Regulated Authorization for AMLODIPIN-RATIOPHARM 5 MGTablett5mg"
Description: "Regulated Authorization for amlodipiin"
Usage: #example
//* id = "" 
//* identifier.system = $spor-prod
* identifier.value = "537307"
//* identifier.use = #official
// Reference to MedicinalProductDefinition:
//MPD
* subject = Reference(mp-0117d414f0e94ef69e054e81654d62c7)

* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000388 "Republic of Estonia"
* status = $100000072049#100000072099  "Valid"

 
* statusDate = "2007-02-12"
* holder = Reference(ORG-100001437)

Instance: auth-for-5dec8cae99ee2a66435dd08db660c4f6
InstanceOf: PPLRegulatedAuthorization
Title: "Regulated Authorization for COVERAMTablett5mg, 10mg"
Description: "Regulated Authorization for perindopriil, amlodipiin"
Usage: #example
//* id = "" 
//* identifier.system = $spor-prod
* identifier.value = "584408"
//* identifier.use = #official
// Reference to MedicinalProductDefinition:
//MPD
* subject = Reference(mp-5dec8cae99ee2a66435dd08db660c4f6)

* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000388 "Republic of Estonia"
* status = $100000072049#100000072099  "Valid"

 
* statusDate = "2008-05-16"
* holder = Reference(ORG-100000964)

Instance: auth-for-04ef0a7061a4691dec54feb8074836ce
InstanceOf: PPLRegulatedAuthorization
Title: "Regulated Authorization for DALNESSANEOTablett5mg"
Description: "Regulated Authorization for amlodipiin, perindopriil"
Usage: #example
//* id = "" 
//* identifier.system = $spor-prod
* identifier.value = "1051422"
//* identifier.use = #official
// Reference to MedicinalProductDefinition:
//MPD
* subject = Reference(mp-04ef0a7061a4691dec54feb8074836ce)

* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000388 "Republic of Estonia"
* status = $100000072049#100000072099  "Valid"

 
* statusDate = "2022-02-08"
* holder = Reference(ORG-100000627)

Instance: auth-for-2e5db5eb34247c26e6a5068649e59e59
InstanceOf: PPLRegulatedAuthorization
Title: "Regulated Authorization for AMLODIGAMMA 5MGTablett5mg"
Description: "Regulated Authorization for amlodipiin"
Usage: #example
//* id = "" 
//* identifier.system = $spor-prod
* identifier.value = "527206"
//* identifier.use = #official
// Reference to MedicinalProductDefinition:
//MPD
* subject = Reference(mp-2e5db5eb34247c26e6a5068649e59e59)

* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000388 "Republic of Estonia"
* status = $100000072049#100000072099  "Valid"

 
* statusDate = "2006-10-20"
* holder = Reference(ORG-100000454)

Instance: auth-for-7b964a36fdf01a567a11fe1f16af2509
InstanceOf: PPLRegulatedAuthorization
Title: "Regulated Authorization for PERINDOPRIL/AMLODIPINE TEVATablett10mg, 5mg"
Description: "Regulated Authorization for amlodipiin, perindopriil"
Usage: #example
//* id = "" 
//* identifier.system = $spor-prod
* identifier.value = "838714"
//* identifier.use = #official
// Reference to MedicinalProductDefinition:
//MPD
* subject = Reference(mp-7b964a36fdf01a567a11fe1f16af2509)

* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000388 "Republic of Estonia"
* status = $100000072049#100000072099  "Valid"

 
* statusDate = "2014-02-28"
* holder = Reference(ORG-100000229)

Instance: auth-for-1cdcca6fa730ec5b4058006fad6b601d
InstanceOf: PPLRegulatedAuthorization
Title: "Regulated Authorization for AMALORISÕhukese polümeerikattega tablett10mg"
Description: "Regulated Authorization for atorvastatiin, amlodipiin"
Usage: #example
//* id = "" 
//* identifier.system = $spor-prod
* identifier.value = "811513"
//* identifier.use = #official
// Reference to MedicinalProductDefinition:
//MPD
* subject = Reference(mp-1cdcca6fa730ec5b4058006fad6b601d)

* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000388 "Republic of Estonia"
* status = $100000072049#100000072099  "Valid"

 
* statusDate = "2013-03-28"
* holder = Reference(ORG-100000627)

Instance: auth-for-822bf262c1257145abe4a7e648bb8314
InstanceOf: PPLRegulatedAuthorization
Title: "Regulated Authorization for OLSITRIÕhukese polümeerikattega tablett5mg, 25mg, 40mg"
Description: "Regulated Authorization for hüdroklorotiasiid, olmesartaanmedoksomiil, amlodipiin"
Usage: #example
//* id = "" 
//* identifier.system = $spor-prod
* identifier.value = "1007920"
//* identifier.use = #official
// Reference to MedicinalProductDefinition:
//MPD
* subject = Reference(mp-822bf262c1257145abe4a7e648bb8314)

* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000388 "Republic of Estonia"
* status = $100000072049#100000072099  "Valid"

 
* statusDate = "2020-06-25"
* holder = Reference(ORG-100000627)

Instance: auth-for-bd1758b2cb3e910f68820e915408a2af
InstanceOf: PPLRegulatedAuthorization
Title: "Regulated Authorization for RAMDACORDIAKõvakapsel5mg"
Description: "Regulated Authorization for amlodipiin, ramipriil"
Usage: #example
//* id = "" 
//* identifier.system = $spor-prod
* identifier.value = "785912"
//* identifier.use = #official
// Reference to MedicinalProductDefinition:
//MPD
* subject = Reference(mp-bd1758b2cb3e910f68820e915408a2af)

* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000388 "Republic of Estonia"
* status = $100000072049#100000072099  "Valid"

 
* statusDate = "2012-05-04"
* holder = Reference(ORG-100002040)

Instance: auth-for-9ca15499bf1142e8576b8b6e580bd9e1
InstanceOf: PPLRegulatedAuthorization
Title: "Regulated Authorization for GADUARÕhukese polümeerikattega tablett10mg, 12.5mg, 40mg"
Description: "Regulated Authorization for olmesartaanmedoksomiil, hüdroklorotiasiid, amlodipiin"
Usage: #example
//* id = "" 
//* identifier.system = $spor-prod
* identifier.value = "1004620"
//* identifier.use = #official
// Reference to MedicinalProductDefinition:
//MPD
* subject = Reference(mp-9ca15499bf1142e8576b8b6e580bd9e1)

* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000388 "Republic of Estonia"
* status = $100000072049#100000072099  "Valid"

 
* statusDate = "2020-04-23"
* holder = Reference(ORG-100004108)

Instance: auth-for-2e0f5028b41c38f94c1f052e63a6cc35
InstanceOf: PPLRegulatedAuthorization
Title: "Regulated Authorization for SOBYCOMBITablett5mg, 10mg"
Description: "Regulated Authorization for amlodipiin, bisoprolool"
Usage: #example
//* id = "" 
//* identifier.system = $spor-prod
* identifier.value = "850414"
//* identifier.use = #official
// Reference to MedicinalProductDefinition:
//MPD
* subject = Reference(mp-2e0f5028b41c38f94c1f052e63a6cc35)

* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000388 "Republic of Estonia"
* status = $100000072049#100000072099  "Valid"

 
* statusDate = "2014-09-15"
* holder = Reference(ORG-100000627)

Instance: auth-for-36612c13eefc42ade6ee4c308534674d
InstanceOf: PPLRegulatedAuthorization
Title: "Regulated Authorization for DALNESSATablett8mg, 10mg"
Description: "Regulated Authorization for amlodipiin, perindopriil"
Usage: #example
//* id = "" 
//* identifier.system = $spor-prod
* identifier.value = "802012"
//* identifier.use = #official
// Reference to MedicinalProductDefinition:
//MPD
* subject = Reference(mp-36612c13eefc42ade6ee4c308534674d)

* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000388 "Republic of Estonia"
* status = $100000072049#100000072099  "Valid"

 
* statusDate = "2012-11-30"
* holder = Reference(ORG-100000627)

Instance: auth-for-24cd67e3d39b3520d2989d16e5c021b0
InstanceOf: PPLRegulatedAuthorization
Title: "Regulated Authorization for SANORALÕhukese polümeerikattega tablett5mg, 20mg"
Description: "Regulated Authorization for olmesartaanmedoksomiil, amlodipiin"
Usage: #example
//* id = "" 
//* identifier.system = $spor-prod
* identifier.value = "606208"
//* identifier.use = #official
// Reference to MedicinalProductDefinition:
//MPD
* subject = Reference(mp-24cd67e3d39b3520d2989d16e5c021b0)

* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000388 "Republic of Estonia"
* status = $100000072049#100000072099  "Valid"

 
* statusDate = "2008-10-31"
* holder = Reference(ORG-100001429)

Instance: auth-for-4b344cb66e0bc241725ca467be44dc84
InstanceOf: PPLRegulatedAuthorization
Title: "Regulated Authorization for TELMISARTAN/AMLODIPINE ALEMBICTablett80mg, 5mg"
Description: "Regulated Authorization for amlodipiin, telmisartaan"
Usage: #example
//* id = "" 
//* identifier.system = $spor-prod
* identifier.value = "1024321"
//* identifier.use = #official
// Reference to MedicinalProductDefinition:
//MPD
* subject = Reference(mp-4b344cb66e0bc241725ca467be44dc84)

* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000388 "Republic of Estonia"
* status = $100000072049#100000072099  "Valid"

 
* statusDate = "2021-03-03"
* holder = Reference(ORG-100007006)

Instance: auth-for-f3e04259c844917fef0e2e775bf07ab8
InstanceOf: PPLRegulatedAuthorization
Title: "Regulated Authorization for SOBYCOMBITablett10mg, 5mg"
Description: "Regulated Authorization for amlodipiin, bisoprolool"
Usage: #example
//* id = "" 
//* identifier.system = $spor-prod
* identifier.value = "850714"
//* identifier.use = #official
// Reference to MedicinalProductDefinition:
//MPD
* subject = Reference(mp-f3e04259c844917fef0e2e775bf07ab8)

* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000388 "Republic of Estonia"
* status = $100000072049#100000072099  "Valid"

 
* statusDate = "2014-09-15"
* holder = Reference(ORG-100000627)

Instance: auth-for-0ecfe6182781ff486fe5156d2e85c11d
InstanceOf: PPLRegulatedAuthorization
Title: "Regulated Authorization for OLSSAÕhukese polümeerikattega tablett40mg, 5mg"
Description: "Regulated Authorization for amlodipiin, olmesartaanmedoksomiil"
Usage: #example
//* id = "" 
//* identifier.system = $spor-prod
* identifier.value = "949717"
//* identifier.use = #official
// Reference to MedicinalProductDefinition:
//MPD
* subject = Reference(mp-0ecfe6182781ff486fe5156d2e85c11d)

* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000388 "Republic of Estonia"
* status = $100000072049#100000072099  "Valid"

 
* statusDate = "2017-09-12"
* holder = Reference(ORG-100000627)

Instance: auth-for-fc27658a5ee9b0a60e09b35c85abc590
InstanceOf: PPLRegulatedAuthorization
Title: "Regulated Authorization for DIPPERAM HCTÕhukese polümeerikattega tablett25mg, 160mg, 5mg"
Description: "Regulated Authorization for valsartaan, amlodipiin, hüdroklorotiasiid"
Usage: #example
//* id = "" 
//* identifier.system = $spor-prod
* identifier.value = "990319"
//* identifier.use = #official
// Reference to MedicinalProductDefinition:
//MPD
* subject = Reference(mp-fc27658a5ee9b0a60e09b35c85abc590)

* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000388 "Republic of Estonia"
* status = $100000072049#100000072099  "Valid"

 
* statusDate = "2019-07-02"
* holder = Reference(ORG-100002040)

Instance: auth-for-04e4154a2d9512b5540cc5bcea914d29
InstanceOf: PPLRegulatedAuthorization
Title: "Regulated Authorization for DIPPERAM HCTÕhukese polümeerikattega tablett25mg, 160mg, 10mg"
Description: "Regulated Authorization for hüdroklorotiasiid, valsartaan, amlodipiin"
Usage: #example
//* id = "" 
//* identifier.system = $spor-prod
* identifier.value = "990519"
//* identifier.use = #official
// Reference to MedicinalProductDefinition:
//MPD
* subject = Reference(mp-04e4154a2d9512b5540cc5bcea914d29)

* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000388 "Republic of Estonia"
* status = $100000072049#100000072099  "Valid"

 
* statusDate = "2019-07-02"
* holder = Reference(ORG-100002040)

Instance: auth-for-ce8886dfb264fe69c15c1bdf0b8ccdbd
InstanceOf: PPLRegulatedAuthorization
Title: "Regulated Authorization for DIPPERAM HCTÕhukese polümeerikattega tablett5mg, 160mg, 12.5mg"
Description: "Regulated Authorization for hüdroklorotiasiid, valsartaan, amlodipiin"
Usage: #example
//* id = "" 
//* identifier.system = $spor-prod
* identifier.value = "990219"
//* identifier.use = #official
// Reference to MedicinalProductDefinition:
//MPD
* subject = Reference(mp-ce8886dfb264fe69c15c1bdf0b8ccdbd)

* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000388 "Republic of Estonia"
* status = $100000072049#100000072099  "Valid"

 
* statusDate = "2019-07-02"
* holder = Reference(ORG-100002040)

Instance: auth-for-992fceef0cf23c5984e1f6197129ac49
InstanceOf: PPLRegulatedAuthorization
Title: "Regulated Authorization for OLSSAÕhukese polümeerikattega tablett40mg, 10mg"
Description: "Regulated Authorization for amlodipiin, olmesartaanmedoksomiil"
Usage: #example
//* id = "" 
//* identifier.system = $spor-prod
* identifier.value = "949817"
//* identifier.use = #official
// Reference to MedicinalProductDefinition:
//MPD
* subject = Reference(mp-992fceef0cf23c5984e1f6197129ac49)

* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000388 "Republic of Estonia"
* status = $100000072049#100000072099  "Valid"

 
* statusDate = "2017-09-12"
* holder = Reference(ORG-100000627)

Instance: auth-for-6227ac6b56beba19e4eafb42abf02d63
InstanceOf: PPLRegulatedAuthorization
Title: "Regulated Authorization for RAMDACORDIA HCTKõvakapsel5mg, 12.5mg"
Description: "Regulated Authorization for ramipriil, hüdroklorotiasiid, amlodipiin"
Usage: #example
//* id = "" 
//* identifier.system = $spor-prod
* identifier.value = "981419"
//* identifier.use = #official
// Reference to MedicinalProductDefinition:
//MPD
* subject = Reference(mp-6227ac6b56beba19e4eafb42abf02d63)

* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000388 "Republic of Estonia"
* status = $100000072049#100000072099  "Valid"

 
* statusDate = "2019-03-05"
* holder = Reference(ORG-100002040)

Instance: auth-for-3744649b31f6f96644d8fdd289e37a6a
InstanceOf: PPLRegulatedAuthorization
Title: "Regulated Authorization for OLMESARTAN MEDOXOMIL/AMLODIPINE/HCT ACCORDÕhukese polümeerikattega tablett5mg, 12.5mg, 40mg"
Description: "Regulated Authorization for olmesartaanmedoksomiil, hüdroklorotiasiid, amlodipiin"
Usage: #example
//* id = "" 
//* identifier.system = $spor-prod
* identifier.value = "1007520"
//* identifier.use = #official
// Reference to MedicinalProductDefinition:
//MPD
* subject = Reference(mp-3744649b31f6f96644d8fdd289e37a6a)

* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000388 "Republic of Estonia"
* status = $100000072049#100000072099  "Valid"

 
* statusDate = "2020-06-25"
* holder = Reference(ORG-100003704)

Instance: auth-for-0d047d5dd4bce354fa4d853f93a71330
InstanceOf: PPLRegulatedAuthorization
Title: "Regulated Authorization for DALNESSANEOTablett5mg, 10mg"
Description: "Regulated Authorization for amlodipiin, perindopriil"
Usage: #example
//* id = "" 
//* identifier.system = $spor-prod
* identifier.value = "1051622"
//* identifier.use = #official
// Reference to MedicinalProductDefinition:
//MPD
* subject = Reference(mp-0d047d5dd4bce354fa4d853f93a71330)

* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000388 "Republic of Estonia"
* status = $100000072049#100000072099  "Valid"

 
* statusDate = "2022-02-08"
* holder = Reference(ORG-100000627)

Instance: auth-for-31917c274c465c03872ca5e6afa9d272
InstanceOf: PPLRegulatedAuthorization
Title: "Regulated Authorization for OLMESARTAN MEDOXOMIL/AMLODIPINE/HYDROCHLOROTHIAZIDE TEVAÕhukese polümeerikattega tablett5mg, 12.5mg, 40mg"
Description: "Regulated Authorization for hüdroklorotiasiid, olmesartaanmedoksomiil, amlodipiin"
Usage: #example
//* id = "" 
//* identifier.system = $spor-prod
* identifier.value = "1017420"
//* identifier.use = #official
// Reference to MedicinalProductDefinition:
//MPD
* subject = Reference(mp-31917c274c465c03872ca5e6afa9d272)

* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000388 "Republic of Estonia"
* status = $100000072049#100000072099  "Valid"

 
* statusDate = "2020-12-29"
* holder = Reference(ORG-100002999)

Instance: auth-for-14e2357708838872a1c59cb5ba1b29be
InstanceOf: PPLRegulatedAuthorization
Title: "Regulated Authorization for RAMDACORDIAKõvakapsel10mg, 5mg"
Description: "Regulated Authorization for amlodipiin, ramipriil"
Usage: #example
//* id = "" 
//* identifier.system = $spor-prod
* identifier.value = "785812"
//* identifier.use = #official
// Reference to MedicinalProductDefinition:
//MPD
* subject = Reference(mp-14e2357708838872a1c59cb5ba1b29be)

* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000388 "Republic of Estonia"
* status = $100000072049#100000072099  "Valid"

 
* statusDate = "2012-05-04"
* holder = Reference(ORG-100002040)

Instance: auth-for-a27716e21b4d7cc9ffb8f51b000f4ba1
InstanceOf: PPLRegulatedAuthorization
Title: "Regulated Authorization for ROXAMPEXÕhukese polümeerikattega tablett10mg, 8mg"
Description: "Regulated Authorization for rosuvastatiin, amlodipiin, perindopriil"
Usage: #example
//* id = "" 
//* identifier.system = $spor-prod
* identifier.value = "996519"
//* identifier.use = #official
// Reference to MedicinalProductDefinition:
//MPD
* subject = Reference(mp-a27716e21b4d7cc9ffb8f51b000f4ba1)

* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000388 "Republic of Estonia"
* status = $100000072049#100000072099  "Valid"

 
* statusDate = "2019-11-04"
* holder = Reference(ORG-100000627)

Instance: auth-for-4d3261ec077923bcb748e081b4a9b4f4
InstanceOf: PPLRegulatedAuthorization
Title: "Regulated Authorization for MIXORTablett80mg, 10mg"
Description: "Regulated Authorization for telmisartaan, amlodipiin"
Usage: #example
//* id = "" 
//* identifier.system = $spor-prod
* identifier.value = "882415"
//* identifier.use = #official
// Reference to MedicinalProductDefinition:
//MPD
* subject = Reference(mp-4d3261ec077923bcb748e081b4a9b4f4)

* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000388 "Republic of Estonia"
* status = $100000072049#100000072099  "Valid"

 
* statusDate = "2015-09-16"
* holder = Reference(ORG-100004108)

Instance: auth-for-60912ca23996a0bb672d0ccf853fe7b4
InstanceOf: PPLRegulatedAuthorization
Title: "Regulated Authorization for AMALORISÕhukese polümeerikattega tablett10mg, 5mg"
Description: "Regulated Authorization for atorvastatiin, amlodipiin"
Usage: #example
//* id = "" 
//* identifier.system = $spor-prod
* identifier.value = "845714"
//* identifier.use = #official
// Reference to MedicinalProductDefinition:
//MPD
* subject = Reference(mp-60912ca23996a0bb672d0ccf853fe7b4)

* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000388 "Republic of Estonia"
* status = $100000072049#100000072099  "Valid"

 
* statusDate = "2014-05-26"
* holder = Reference(ORG-100000627)

Instance: auth-for-94c09fe7996b6f1c26c7ef488b62c37d
InstanceOf: PPLRegulatedAuthorization
Title: "Regulated Authorization for TELMISARTAN/AMLODIPINE ALEMBICTablett40mg, 10mg"
Description: "Regulated Authorization for telmisartaan, amlodipiin"
Usage: #example
//* id = "" 
//* identifier.system = $spor-prod
* identifier.value = "1024221"
//* identifier.use = #official
// Reference to MedicinalProductDefinition:
//MPD
* subject = Reference(mp-94c09fe7996b6f1c26c7ef488b62c37d)

* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000388 "Republic of Estonia"
* status = $100000072049#100000072099  "Valid"

 
* statusDate = "2021-03-03"
* holder = Reference(ORG-100007006)

Instance: auth-for-4569c44a7c8e676897f534300d7dbbaa
InstanceOf: PPLRegulatedAuthorization
Title: "Regulated Authorization for VALTRICOMÕhukese polümeerikattega tablett160mg, 5mg, 25mg"
Description: "Regulated Authorization for valsartaan, hüdroklorotiasiid, amlodipiin"
Usage: #example
//* id = "" 
//* identifier.system = $spor-prod
* identifier.value = "982519"
//* identifier.use = #official
// Reference to MedicinalProductDefinition:
//MPD
* subject = Reference(mp-4569c44a7c8e676897f534300d7dbbaa)

* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000388 "Republic of Estonia"
* status = $100000072049#100000072099  "Valid"

 
* statusDate = "2019-03-05"
* holder = Reference(ORG-100000627)

Instance: auth-for-889b2b047c2dbf68778b1904db196833
InstanceOf: PPLRegulatedAuthorization
Title: "Regulated Authorization for RAMDACORDIA HCTKõvakapsel25mg, 5mg"
Description: "Regulated Authorization for hüdroklorotiasiid, ramipriil, amlodipiin"
Usage: #example
//* id = "" 
//* identifier.system = $spor-prod
* identifier.value = "981519"
//* identifier.use = #official
// Reference to MedicinalProductDefinition:
//MPD
* subject = Reference(mp-889b2b047c2dbf68778b1904db196833)

* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000388 "Republic of Estonia"
* status = $100000072049#100000072099  "Valid"

 
* statusDate = "2019-03-05"
* holder = Reference(ORG-100002040)

Instance: auth-for-04fd98885e4ce4db86cf32c2d36e5aa8
InstanceOf: PPLRegulatedAuthorization
Title: "Regulated Authorization for OLMESARTAN MEDOXOMIL/AMLODIPINE/HYDROCHLOROTHIAZIDE ALEMBICÕhukese polümeerikattega tablett25mg, 5mg, 40mg"
Description: "Regulated Authorization for hüdroklorotiasiid, amlodipiin, olmesartaanmedoksomiil"
Usage: #example
//* id = "" 
//* identifier.system = $spor-prod
* identifier.value = "1023621"
//* identifier.use = #official
// Reference to MedicinalProductDefinition:
//MPD
* subject = Reference(mp-04fd98885e4ce4db86cf32c2d36e5aa8)

* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000388 "Republic of Estonia"
* status = $100000072049#100000072099  "Valid"

 
* statusDate = "2021-03-03"
* holder = Reference(ORG-100007006)

Instance: auth-for-8b716ee61fa4aa41e504fb7b8cc10966
InstanceOf: PPLRegulatedAuthorization
Title: "Regulated Authorization for DALNESSATablett4mg, 10mg"
Description: "Regulated Authorization for perindopriil, amlodipiin"
Usage: #example
//* id = "" 
//* identifier.system = $spor-prod
* identifier.value = "802312"
//* identifier.use = #official
// Reference to MedicinalProductDefinition:
//MPD
* subject = Reference(mp-8b716ee61fa4aa41e504fb7b8cc10966)

* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000388 "Republic of Estonia"
* status = $100000072049#100000072099  "Valid"

 
* statusDate = "2012-11-30"
* holder = Reference(ORG-100000627)

Instance: auth-for-d89ec52c740c99583c8334e1d265efd2
InstanceOf: PPLRegulatedAuthorization
Title: "Regulated Authorization for RAMDACORDIAKõvakapsel10mg, 5mg"
Description: "Regulated Authorization for ramipriil, amlodipiin"
Usage: #example
//* id = "" 
//* identifier.system = $spor-prod
* identifier.value = "785612"
//* identifier.use = #official
// Reference to MedicinalProductDefinition:
//MPD
* subject = Reference(mp-d89ec52c740c99583c8334e1d265efd2)

* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000388 "Republic of Estonia"
* status = $100000072049#100000072099  "Valid"

 
* statusDate = "2012-05-04"
* holder = Reference(ORG-100002040)

Instance: auth-for-790c3262fcb36ab4153d147d79fb4390
InstanceOf: PPLRegulatedAuthorization
Title: "Regulated Authorization for AMLODIPINE MEDOCHEMIETablett5mg"
Description: "Regulated Authorization for amlodipiin"
Usage: #example
//* id = "" 
//* identifier.system = $spor-prod
* identifier.value = "567307"
//* identifier.use = #official
// Reference to MedicinalProductDefinition:
//MPD
* subject = Reference(mp-790c3262fcb36ab4153d147d79fb4390)

* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000388 "Republic of Estonia"
* status = $100000072049#100000072099  "Valid"

 
* statusDate = "2007-12-14"
* holder = Reference(MO11501)

Instance: auth-for-e7ee4d9735c9b48b2998e52eb7179ed5
InstanceOf: PPLRegulatedAuthorization
Title: "Regulated Authorization for AMLOCARD 10MGTablett10mg"
Description: "Regulated Authorization for amlodipiin"
Usage: #example
//* id = "" 
//* identifier.system = $spor-prod
* identifier.value = "538707"
//* identifier.use = #official
// Reference to MedicinalProductDefinition:
//MPD
* subject = Reference(mp-e7ee4d9735c9b48b2998e52eb7179ed5)

* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000388 "Republic of Estonia"
* status = $100000072049#100000072099  "Valid"

 
* statusDate = "2007-02-12"
* holder = Reference(ORG-100000313)

Instance: auth-for-56dfd3ef23616a17c8516e86c896c63b
InstanceOf: PPLRegulatedAuthorization
Title: "Regulated Authorization for TELMISARTAN/AMLODIPINE TEVATablett10mg, 80mg"
Description: "Regulated Authorization for amlodipiin, telmisartaan"
Usage: #example
//* id = "" 
//* identifier.system = $spor-prod
* identifier.value = "1062622"
//* identifier.use = #official
// Reference to MedicinalProductDefinition:
//MPD
* subject = Reference(mp-56dfd3ef23616a17c8516e86c896c63b)

* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000388 "Republic of Estonia"
* status = $100000072049#100000072099  "Valid"

 
* statusDate = "2022-05-09"
* holder = Reference(ORG-100002999)

Instance: auth-for-928926c8a307b3b3a8d3551a8fc10bde
InstanceOf: PPLRegulatedAuthorization
Title: "Regulated Authorization for OLMESARTAN MEDOXOMIL/AMLODIPINE KRKAÕhukese polümeerikattega tablett5mg, 20mg"
Description: "Regulated Authorization for olmesartaanmedoksomiil, amlodipiin"
Usage: #example
//* id = "" 
//* identifier.system = $spor-prod
* identifier.value = "991119"
//* identifier.use = #official
// Reference to MedicinalProductDefinition:
//MPD
* subject = Reference(mp-928926c8a307b3b3a8d3551a8fc10bde)

* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000388 "Republic of Estonia"
* status = $100000072049#100000072099  "Valid"

 
* statusDate = "2019-07-02"
* holder = Reference(ORG-100000627)

Instance: auth-for-d59d10dac3a35bfeb925aebce3fcfa04
InstanceOf: PPLRegulatedAuthorization
Title: "Regulated Authorization for DIRONORMTablett20mg, 5mg"
Description: "Regulated Authorization for lisinopriil, amlodipiin"
Usage: #example
//* id = "" 
//* identifier.system = $spor-prod
* identifier.value = "780112"
//* identifier.use = #official
// Reference to MedicinalProductDefinition:
//MPD
* subject = Reference(mp-d59d10dac3a35bfeb925aebce3fcfa04)

* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000388 "Republic of Estonia"
* status = $100000072049#100000072099  "Valid"

 
* statusDate = "2012-03-01"
* holder = Reference(ORG-100000640)

Instance: auth-for-d3a126b8227e56f2155ae740e9723dc2
InstanceOf: PPLRegulatedAuthorization
Title: "Regulated Authorization for TELDIPINTablett5mg, 40mg"
Description: "Regulated Authorization for telmisartaan, amlodipiin"
Usage: #example
//* id = "" 
//* identifier.system = $spor-prod
* identifier.value = "929516"
//* identifier.use = #official
// Reference to MedicinalProductDefinition:
//MPD
* subject = Reference(mp-d3a126b8227e56f2155ae740e9723dc2)

* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000388 "Republic of Estonia"
* status = $100000072049#100000072099  "Valid"

 
* statusDate = "2017-01-10"
* holder = Reference(ORG-100000627)

Instance: auth-for-a823dbe22a8d12bb4bc87e4bdbdbb0b9
InstanceOf: PPLRegulatedAuthorization
Title: "Regulated Authorization for TELMISARTAN/AMLODIPINE ALEMBICTablett40mg, 5mg"
Description: "Regulated Authorization for telmisartaan, amlodipiin"
Usage: #example
//* id = "" 
//* identifier.system = $spor-prod
* identifier.value = "1024121"
//* identifier.use = #official
// Reference to MedicinalProductDefinition:
//MPD
* subject = Reference(mp-a823dbe22a8d12bb4bc87e4bdbdbb0b9)

* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000388 "Republic of Estonia"
* status = $100000072049#100000072099  "Valid"

 
* statusDate = "2021-03-03"
* holder = Reference(ORG-100007006)

Instance: auth-for-0b5de376a6e3694afd4c906d71a20a93
InstanceOf: PPLRegulatedAuthorization
Title: "Regulated Authorization for ALNETATablett10mg"
Description: "Regulated Authorization for amlodipiin"
Usage: #example
//* id = "" 
//* identifier.system = $spor-prod
* identifier.value = "808213"
//* identifier.use = #official
// Reference to MedicinalProductDefinition:
//MPD
* subject = Reference(mp-0b5de376a6e3694afd4c906d71a20a93)

* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000388 "Republic of Estonia"
* status = $100000072049#100000072099  "Valid"

 
* statusDate = "2013-03-04"
* holder = Reference(ORG-100000627)

Instance: auth-for-1141aae8513eb520117974def513abbe
InstanceOf: PPLRegulatedAuthorization
Title: "Regulated Authorization for CO-DALNESSATablett1.25mg, 5mg, 4mg"
Description: "Regulated Authorization for amlodipiin, indapamiid, perindopriil"
Usage: #example
//* id = "" 
//* identifier.system = $spor-prod
* identifier.value = "833113"
//* identifier.use = #official
// Reference to MedicinalProductDefinition:
//MPD
* subject = Reference(mp-1141aae8513eb520117974def513abbe)

* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000388 "Republic of Estonia"
* status = $100000072049#100000072099  "Valid"

 
* statusDate = "2013-12-20"
* holder = Reference(ORG-100000627)

Instance: auth-for-ebae77533e4c1e728b99e03b2085351b
InstanceOf: PPLRegulatedAuthorization
Title: "Regulated Authorization for OLMESARTAN MEDOXOMIL/AMLODIPINE ACCORDÕhukese polümeerikattega tablett40mg, 10mg"
Description: "Regulated Authorization for amlodipiin, olmesartaanmedoksomiil"
Usage: #example
//* id = "" 
//* identifier.system = $spor-prod
* identifier.value = "957417"
//* identifier.use = #official
// Reference to MedicinalProductDefinition:
//MPD
* subject = Reference(mp-ebae77533e4c1e728b99e03b2085351b)

* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000388 "Republic of Estonia"
* status = $100000072049#100000072099  "Valid"

 
* statusDate = "2018-01-08"
* holder = Reference(ORG-100003704)

Instance: auth-for-ea0760856f322e401f457fd499eae073
InstanceOf: PPLRegulatedAuthorization
Title: "Regulated Authorization for OLMESARTAN MEDOXOMIL/AMLODIPINE ZENTIVAÕhukese polümeerikattega tablett40mg, 10mg"
Description: "Regulated Authorization for amlodipiin, olmesartaanmedoksomiil"
Usage: #example
//* id = "" 
//* identifier.system = $spor-prod
* identifier.value = "954617"
//* identifier.use = #official
// Reference to MedicinalProductDefinition:
//MPD
* subject = Reference(mp-ea0760856f322e401f457fd499eae073)

* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000388 "Republic of Estonia"
* status = $100000072049#100000072099  "Valid"

 
* statusDate = "2017-11-07"
* holder = Reference(ORG-100004108)

Instance: auth-for-86b57f03efc0bf7bcdc77d7a8dce3999
InstanceOf: PPLRegulatedAuthorization
Title: "Regulated Authorization for FRAMSYLKõvakapsel5mg, 16mg"
Description: "Regulated Authorization for kandesartaan, amlodipiin"
Usage: #example
//* id = "" 
//* identifier.system = $spor-prod
* identifier.value = "915816"
//* identifier.use = #official
// Reference to MedicinalProductDefinition:
//MPD
* subject = Reference(mp-86b57f03efc0bf7bcdc77d7a8dce3999)

* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000388 "Republic of Estonia"
* status = $100000072049#100000072099  "Valid"

 
* statusDate = "2016-09-13"
* holder = Reference(ORG-100002040)

Instance: auth-for-473963e88b785cfc16808e8769caf412
InstanceOf: PPLRegulatedAuthorization
Title: "Regulated Authorization for DALNESSATablett5.7mg, 5mg"
Description: "Regulated Authorization for perindopriil, amlodipiin"
Usage: #example
//* id = "" 
//* identifier.system = $spor-prod
* identifier.value = "969418"
//* identifier.use = #official
// Reference to MedicinalProductDefinition:
//MPD
* subject = Reference(mp-473963e88b785cfc16808e8769caf412)

* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000388 "Republic of Estonia"
* status = $100000072049#100000072099  "Valid"

 
* statusDate = "2018-09-11"
* holder = Reference(ORG-100000627)

Instance: auth-for-a380cadd3016c2a5d946b4f3003865c0
InstanceOf: PPLRegulatedAuthorization
Title: "Regulated Authorization for TELMISARTAN/AMLODIPINE TEVATablett80mg, 5mg"
Description: "Regulated Authorization for telmisartaan, amlodipiin"
Usage: #example
//* id = "" 
//* identifier.system = $spor-prod
* identifier.value = "1062522"
//* identifier.use = #official
// Reference to MedicinalProductDefinition:
//MPD
* subject = Reference(mp-a380cadd3016c2a5d946b4f3003865c0)

* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000388 "Republic of Estonia"
* status = $100000072049#100000072099  "Valid"

 
* statusDate = "2022-05-09"
* holder = Reference(ORG-100002999)

Instance: auth-for-4648373e4938d96c51d667392632f991
InstanceOf: PPLRegulatedAuthorization
Title: "Regulated Authorization for DALNESSANEOTablett10mg"
Description: "Regulated Authorization for perindopriil, amlodipiin"
Usage: #example
//* id = "" 
//* identifier.system = $spor-prod
* identifier.value = "1051722"
//* identifier.use = #official
// Reference to MedicinalProductDefinition:
//MPD
* subject = Reference(mp-4648373e4938d96c51d667392632f991)

* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000388 "Republic of Estonia"
* status = $100000072049#100000072099  "Valid"

 
* statusDate = "2022-02-08"
* holder = Reference(ORG-100000627)

Instance: auth-for-57c88696b92540a20d8687d5705cc3a7
InstanceOf: PPLRegulatedAuthorization
Title: "Regulated Authorization for PERINDOPRIL/ AMLODIPINE ACTAVISTablett10mg, 5mg"
Description: "Regulated Authorization for amlodipiin, perindopriil"
Usage: #example
//* id = "" 
//* identifier.system = $spor-prod
* identifier.value = "1040421"
//* identifier.use = #official
// Reference to MedicinalProductDefinition:
//MPD
* subject = Reference(mp-57c88696b92540a20d8687d5705cc3a7)

* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000388 "Republic of Estonia"
* status = $100000072049#100000072099  "Valid"

 
* statusDate = "2021-09-15"
* holder = Reference(ORG-100000064)

Instance: auth-for-2df1fd096ea2119e34f58eeaf76f3361
InstanceOf: PPLRegulatedAuthorization
Title: "Regulated Authorization for CO-DALNESSATablett8mg, 2.5mg, 10mg"
Description: "Regulated Authorization for amlodipiin, indapamiid, perindopriil"
Usage: #example
//* id = "" 
//* identifier.system = $spor-prod
* identifier.value = "833213"
//* identifier.use = #official
// Reference to MedicinalProductDefinition:
//MPD
* subject = Reference(mp-2df1fd096ea2119e34f58eeaf76f3361)

* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000388 "Republic of Estonia"
* status = $100000072049#100000072099  "Valid"

 
* statusDate = "2013-12-20"
* holder = Reference(ORG-100000627)

Instance: auth-for-92deca0aa200157ff667b54187059631
InstanceOf: PPLRegulatedAuthorization
Title: "Regulated Authorization for OLMESARTAN MEDOXOMIL/AMLODIPINE ACCORDÕhukese polümeerikattega tablett40mg, 5mg"
Description: "Regulated Authorization for amlodipiin, olmesartaanmedoksomiil"
Usage: #example
//* id = "" 
//* identifier.system = $spor-prod
* identifier.value = "957317"
//* identifier.use = #official
// Reference to MedicinalProductDefinition:
//MPD
* subject = Reference(mp-92deca0aa200157ff667b54187059631)

* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000388 "Republic of Estonia"
* status = $100000072049#100000072099  "Valid"

 
* statusDate = "2018-01-08"
* holder = Reference(ORG-100003704)

Instance: auth-for-a452ad2a480e81cd3737925a60ec302c
InstanceOf: PPLRegulatedAuthorization
Title: "Regulated Authorization for DIRONORMTablett10mg, 5mg"
Description: "Regulated Authorization for amlodipiin, lisinopriil"
Usage: #example
//* id = "" 
//* identifier.system = $spor-prod
* identifier.value = "616709"
//* identifier.use = #official
// Reference to MedicinalProductDefinition:
//MPD
* subject = Reference(mp-a452ad2a480e81cd3737925a60ec302c)

* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000388 "Republic of Estonia"
* status = $100000072049#100000072099  "Valid"

 
* statusDate = "2009-02-06"
* holder = Reference(ORG-100000640)

Instance: auth-for-dbdeb2055d677f893444bdcb86676431
InstanceOf: PPLRegulatedAuthorization
Title: "Regulated Authorization for PERINDOPRIL/AMLODIPINE TEVATablett5mg"
Description: "Regulated Authorization for perindopriil, amlodipiin"
Usage: #example
//* id = "" 
//* identifier.system = $spor-prod
* identifier.value = "838814"
//* identifier.use = #official
// Reference to MedicinalProductDefinition:
//MPD
* subject = Reference(mp-dbdeb2055d677f893444bdcb86676431)

* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000388 "Republic of Estonia"
* status = $100000072049#100000072099  "Valid"

 
* statusDate = "2014-02-28"
* holder = Reference(ORG-100000229)

Instance: auth-for-164a8ce3f7e2956d3591764c075e672b
InstanceOf: PPLRegulatedAuthorization
Title: "Regulated Authorization for ROXAMPEXÕhukese polümeerikattega tablett5mg, 4mg, 10mg"
Description: "Regulated Authorization for amlodipiin, rosuvastatiin, perindopriil"
Usage: #example
//* id = "" 
//* identifier.system = $spor-prod
* identifier.value = "996319"
//* identifier.use = #official
// Reference to MedicinalProductDefinition:
//MPD
* subject = Reference(mp-164a8ce3f7e2956d3591764c075e672b)

* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000388 "Republic of Estonia"
* status = $100000072049#100000072099  "Valid"

 
* statusDate = "2019-11-04"
* holder = Reference(ORG-100000627)

Instance: auth-for-c2df63ce4b6e847234f127a936124cee
InstanceOf: PPLRegulatedAuthorization
Title: "Regulated Authorization for OLMESARTAN MEDOXOMIL/AMLODIPINE KRKAÕhukese polümeerikattega tablett40mg, 10mg"
Description: "Regulated Authorization for amlodipiin, olmesartaanmedoksomiil"
Usage: #example
//* id = "" 
//* identifier.system = $spor-prod
* identifier.value = "991319"
//* identifier.use = #official
// Reference to MedicinalProductDefinition:
//MPD
* subject = Reference(mp-c2df63ce4b6e847234f127a936124cee)

* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000388 "Republic of Estonia"
* status = $100000072049#100000072099  "Valid"

 
* statusDate = "2019-07-02"
* holder = Reference(ORG-100000627)

Instance: auth-for-91f76beabfa57c6be6d029c68a5ddf5f
InstanceOf: PPLRegulatedAuthorization
Title: "Regulated Authorization for OLMESARTAN MEDOXOMIL/AMLODIPINE/HCT ACCORDÕhukese polümeerikattega tablett10mg, 40mg, 12.5mg"
Description: "Regulated Authorization for amlodipiin, olmesartaanmedoksomiil, hüdroklorotiasiid"
Usage: #example
//* id = "" 
//* identifier.system = $spor-prod
* identifier.value = "1007620"
//* identifier.use = #official
// Reference to MedicinalProductDefinition:
//MPD
* subject = Reference(mp-91f76beabfa57c6be6d029c68a5ddf5f)

* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000388 "Republic of Estonia"
* status = $100000072049#100000072099  "Valid"

 
* statusDate = "2020-06-25"
* holder = Reference(ORG-100003704)

Instance: auth-for-0522fe195a75b4ffa60e98e2b065d29f
InstanceOf: PPLRegulatedAuthorization
Title: "Regulated Authorization for CO-DALNESSATablett5mg, 8mg, 2.5mg"
Description: "Regulated Authorization for indapamiid, perindopriil, amlodipiin"
Usage: #example
//* id = "" 
//* identifier.system = $spor-prod
* identifier.value = "833313"
//* identifier.use = #official
// Reference to MedicinalProductDefinition:
//MPD
* subject = Reference(mp-0522fe195a75b4ffa60e98e2b065d29f)

* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000388 "Republic of Estonia"
* status = $100000072049#100000072099  "Valid"

 
* statusDate = "2013-12-20"
* holder = Reference(ORG-100000627)

Instance: auth-for-5c042bbd83eb6153724ad890c2412039
InstanceOf: PPLRegulatedAuthorization
Title: "Regulated Authorization for SANORALÕhukese polümeerikattega tablett40mg, 5mg"
Description: "Regulated Authorization for amlodipiin, olmesartaanmedoksomiil"
Usage: #example
//* id = "" 
//* identifier.system = $spor-prod
* identifier.value = "606408"
//* identifier.use = #official
// Reference to MedicinalProductDefinition:
//MPD
* subject = Reference(mp-5c042bbd83eb6153724ad890c2412039)

* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000388 "Republic of Estonia"
* status = $100000072049#100000072099  "Valid"

 
* statusDate = "2008-10-31"
* holder = Reference(ORG-100001429)

Instance: auth-for-43a794a22110d2df504819ad48a456ad
InstanceOf: PPLRegulatedAuthorization
Title: "Regulated Authorization for SANORAL HCTÕhukese polümeerikattega tablett12.5mg, 5mg, 40mg"
Description: "Regulated Authorization for amlodipiin, hüdroklorotiasiid, olmesartaanmedoksomiil"
Usage: #example
//* id = "" 
//* identifier.system = $spor-prod
* identifier.value = "730311"
//* identifier.use = #official
// Reference to MedicinalProductDefinition:
//MPD
* subject = Reference(mp-43a794a22110d2df504819ad48a456ad)

* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000388 "Republic of Estonia"
* status = $100000072049#100000072099  "Valid"

 
* statusDate = "2011-02-01"
* holder = Reference(ORG-100001429)

Instance: auth-for-1d507303f7d371853f158ef9ca580b39
InstanceOf: PPLRegulatedAuthorization
Title: "Regulated Authorization for RAMDACORDIAKõvakapsel10mg"
Description: "Regulated Authorization for amlodipiin, ramipriil"
Usage: #example
//* id = "" 
//* identifier.system = $spor-prod
* identifier.value = "785712"
//* identifier.use = #official
// Reference to MedicinalProductDefinition:
//MPD
* subject = Reference(mp-1d507303f7d371853f158ef9ca580b39)

* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000388 "Republic of Estonia"
* status = $100000072049#100000072099  "Valid"

 
* statusDate = "2012-05-04"
* holder = Reference(ORG-100002040)

Instance: auth-for-9ff8261eb987e544b8510cd3f9a83372
InstanceOf: PPLRegulatedAuthorization
Title: "Regulated Authorization for WAMLOXÕhukese polümeerikattega tablett10mg, 320mg"
Description: "Regulated Authorization for valsartaan, amlodipiin"
Usage: #example
//* id = "" 
//* identifier.system = $spor-prod
* identifier.value = "979719"
//* identifier.use = #official
// Reference to MedicinalProductDefinition:
//MPD
* subject = Reference(mp-9ff8261eb987e544b8510cd3f9a83372)

* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000388 "Republic of Estonia"
* status = $100000072049#100000072099  "Valid"

 
* statusDate = "2019-02-05"
* holder = Reference(ORG-100000627)

Instance: auth-for-37ceb237ec18c2826b5fb5e68f9b2ab7
InstanceOf: PPLRegulatedAuthorization
Title: "Regulated Authorization for PERINDOPRIL/ AMLODIPINE ACTAVISTablett5mg"
Description: "Regulated Authorization for amlodipiin, perindopriil"
Usage: #example
//* id = "" 
//* identifier.system = $spor-prod
* identifier.value = "1040221"
//* identifier.use = #official
// Reference to MedicinalProductDefinition:
//MPD
* subject = Reference(mp-37ceb237ec18c2826b5fb5e68f9b2ab7)

* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000388 "Republic of Estonia"
* status = $100000072049#100000072099  "Valid"

 
* statusDate = "2021-09-15"
* holder = Reference(ORG-100000064)

Instance: auth-for-e8ce73afbb42811b992f84492a92b044
InstanceOf: PPLRegulatedAuthorization
Title: "Regulated Authorization for DALNESSANEOTablett10mg, 5mg"
Description: "Regulated Authorization for amlodipiin, perindopriil"
Usage: #example
//* id = "" 
//* identifier.system = $spor-prod
* identifier.value = "1051522"
//* identifier.use = #official
// Reference to MedicinalProductDefinition:
//MPD
* subject = Reference(mp-e8ce73afbb42811b992f84492a92b044)

* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000388 "Republic of Estonia"
* status = $100000072049#100000072099  "Valid"

 
* statusDate = "2022-02-08"
* holder = Reference(ORG-100000627)

Instance: auth-for-cc8a2cda608c39747a1735d392904ef2
InstanceOf: PPLRegulatedAuthorization
Title: "Regulated Authorization for FRAMSYLKõvakapsel10mg, 8mg"
Description: "Regulated Authorization for amlodipiin, kandesartaan"
Usage: #example
//* id = "" 
//* identifier.system = $spor-prod
* identifier.value = "915716"
//* identifier.use = #official
// Reference to MedicinalProductDefinition:
//MPD
* subject = Reference(mp-cc8a2cda608c39747a1735d392904ef2)

* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000388 "Republic of Estonia"
* status = $100000072049#100000072099  "Valid"

 
* statusDate = "2016-09-13"
* holder = Reference(ORG-100002040)

Instance: auth-for-61e636582ddb3a8fe7f052c5963552b3
InstanceOf: PPLRegulatedAuthorization
Title: "Regulated Authorization for OLMESARTAN MEDOXOMIL/AMLODIPINE/HYDROCHLOROTHIAZIDE TEVAÕhukese polümeerikattega tablett12.5mg, 40mg, 10mg"
Description: "Regulated Authorization for amlodipiin, olmesartaanmedoksomiil, hüdroklorotiasiid"
Usage: #example
//* id = "" 
//* identifier.system = $spor-prod
* identifier.value = "1017520"
//* identifier.use = #official
// Reference to MedicinalProductDefinition:
//MPD
* subject = Reference(mp-61e636582ddb3a8fe7f052c5963552b3)

* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000388 "Republic of Estonia"
* status = $100000072049#100000072099  "Valid"

 
* statusDate = "2020-12-29"
* holder = Reference(ORG-100002999)

Instance: auth-for-17aa3bb6faec404ef2e078cb38f6d778
InstanceOf: PPLRegulatedAuthorization
Title: "Regulated Authorization for AMLODIPIN-RATIOPHARM 10 MGTablett10mg"
Description: "Regulated Authorization for amlodipiin"
Usage: #example
//* id = "" 
//* identifier.system = $spor-prod
* identifier.value = "537207"
//* identifier.use = #official
// Reference to MedicinalProductDefinition:
//MPD
* subject = Reference(mp-17aa3bb6faec404ef2e078cb38f6d778)

* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000388 "Republic of Estonia"
* status = $100000072049#100000072099  "Valid"

 
* statusDate = "2007-02-12"
* holder = Reference(ORG-100001437)

Instance: auth-for-45c118b40b2c28e9ac6cab91e4e07174
InstanceOf: PPLRegulatedAuthorization
Title: "Regulated Authorization for WAMLOXÕhukese polümeerikattega tablett80mg, 5mg"
Description: "Regulated Authorization for amlodipiin, valsartaan"
Usage: #example
//* id = "" 
//* identifier.system = $spor-prod
* identifier.value = "902816"
//* identifier.use = #official
// Reference to MedicinalProductDefinition:
//MPD
* subject = Reference(mp-45c118b40b2c28e9ac6cab91e4e07174)

* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000388 "Republic of Estonia"
* status = $100000072049#100000072099  "Valid"

 
* statusDate = "2016-02-09"
* holder = Reference(ORG-100000627)

Instance: auth-for-6111af384fb679255fb465a3592f66ef
InstanceOf: PPLRegulatedAuthorization
Title: "Regulated Authorization for ROXAMPEXÕhukese polümeerikattega tablett10mg, 5mg, 8mg"
Description: "Regulated Authorization for perindopriil, rosuvastatiin, amlodipiin"
Usage: #example
//* id = "" 
//* identifier.system = $spor-prod
* identifier.value = "996419"
//* identifier.use = #official
// Reference to MedicinalProductDefinition:
//MPD
* subject = Reference(mp-6111af384fb679255fb465a3592f66ef)

* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000388 "Republic of Estonia"
* status = $100000072049#100000072099  "Valid"

 
* statusDate = "2019-11-04"
* holder = Reference(ORG-100000627)

Instance: auth-for-6927a99dccb40876a816618edcdef801
InstanceOf: PPLRegulatedAuthorization
Title: "Regulated Authorization for WAMLOXÕhukese polümeerikattega tablett160mg, 5mg"
Description: "Regulated Authorization for amlodipiin, valsartaan"
Usage: #example
//* id = "" 
//* identifier.system = $spor-prod
* identifier.value = "902916"
//* identifier.use = #official
// Reference to MedicinalProductDefinition:
//MPD
* subject = Reference(mp-6927a99dccb40876a816618edcdef801)

* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000388 "Republic of Estonia"
* status = $100000072049#100000072099  "Valid"

 
* statusDate = "2016-02-09"
* holder = Reference(ORG-100000627)

Instance: auth-for-9cddcc96feade261665f0a3ef5dbe6ea
InstanceOf: PPLRegulatedAuthorization
Title: "Regulated Authorization for AMLOCARD 5 MGTablett5mg"
Description: "Regulated Authorization for amlodipiin"
Usage: #example
//* id = "" 
//* identifier.system = $spor-prod
* identifier.value = "538507"
//* identifier.use = #official
// Reference to MedicinalProductDefinition:
//MPD
* subject = Reference(mp-9cddcc96feade261665f0a3ef5dbe6ea)

* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000388 "Republic of Estonia"
* status = $100000072049#100000072099  "Valid"

 
* statusDate = "2007-02-12"
* holder = Reference(ORG-100000313)

Instance: auth-for-3d3624f68235986f61c909321318e1ef
InstanceOf: PPLRegulatedAuthorization
Title: "Regulated Authorization for COVERAMTablett10mg"
Description: "Regulated Authorization for perindopriil, amlodipiin"
Usage: #example
//* id = "" 
//* identifier.system = $spor-prod
* identifier.value = "584208"
//* identifier.use = #official
// Reference to MedicinalProductDefinition:
//MPD
* subject = Reference(mp-3d3624f68235986f61c909321318e1ef)

* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000388 "Republic of Estonia"
* status = $100000072049#100000072099  "Valid"

 
* statusDate = "2008-05-16"
* holder = Reference(ORG-100000964)

Instance: auth-for-75a6f374ecfe6f4521b39ccaf45991db
InstanceOf: PPLRegulatedAuthorization
Title: "Regulated Authorization for SOBYCOMBITablett5mg"
Description: "Regulated Authorization for amlodipiin, bisoprolool"
Usage: #example
//* id = "" 
//* identifier.system = $spor-prod
* identifier.value = "850614"
//* identifier.use = #official
// Reference to MedicinalProductDefinition:
//MPD
* subject = Reference(mp-75a6f374ecfe6f4521b39ccaf45991db)

* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000388 "Republic of Estonia"
* status = $100000072049#100000072099  "Valid"

 
* statusDate = "2014-09-15"
* holder = Reference(ORG-100000627)

Instance: auth-for-4ae2ae7f133292e2edd393b837ba7475
InstanceOf: PPLRegulatedAuthorization
Title: "Regulated Authorization for DALNESSATablett5mg, 8mg"
Description: "Regulated Authorization for perindopriil, amlodipiin"
Usage: #example
//* id = "" 
//* identifier.system = $spor-prod
* identifier.value = "802112"
//* identifier.use = #official
// Reference to MedicinalProductDefinition:
//MPD
* subject = Reference(mp-4ae2ae7f133292e2edd393b837ba7475)

* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000388 "Republic of Estonia"
* status = $100000072049#100000072099  "Valid"

 
* statusDate = "2012-11-30"
* holder = Reference(ORG-100000627)

Instance: auth-for-87eace728cb772bd744d4c9bd663f8e7
InstanceOf: PPLRegulatedAuthorization
Title: "Regulated Authorization for TRIPLIXAMÕhukese polümeerikattega tablett10mg, 5mg, 1.25mg"
Description: "Regulated Authorization for indapamiid, perindopriil, amlodipiin"
Usage: #example
//* id = "" 
//* identifier.system = $spor-prod
* identifier.value = "834914"
//* identifier.use = #official
// Reference to MedicinalProductDefinition:
//MPD
* subject = Reference(mp-87eace728cb772bd744d4c9bd663f8e7)

* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000388 "Republic of Estonia"
* status = $100000072049#100000072099  "Valid"

 
* statusDate = "2014-01-27"
* holder = Reference(ORG-100000964)

Instance: auth-for-7f36e51dcd3c062fcdfde290213d93fd
InstanceOf: PPLRegulatedAuthorization
Title: "Regulated Authorization for RAMDACORDIA HCTKõvakapsel25mg, 10mg"
Description: "Regulated Authorization for hüdroklorotiasiid, amlodipiin, ramipriil"
Usage: #example
//* id = "" 
//* identifier.system = $spor-prod
* identifier.value = "981719"
//* identifier.use = #official
// Reference to MedicinalProductDefinition:
//MPD
* subject = Reference(mp-7f36e51dcd3c062fcdfde290213d93fd)

* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000388 "Republic of Estonia"
* status = $100000072049#100000072099  "Valid"

 
* statusDate = "2019-03-05"
* holder = Reference(ORG-100002040)

Instance: auth-for-3a50f937e5452c904f583dd60b86c709
InstanceOf: PPLRegulatedAuthorization
Title: "Regulated Authorization for TELDIPINTablett10mg, 40mg"
Description: "Regulated Authorization for amlodipiin, telmisartaan"
Usage: #example
//* id = "" 
//* identifier.system = $spor-prod
* identifier.value = "929616"
//* identifier.use = #official
// Reference to MedicinalProductDefinition:
//MPD
* subject = Reference(mp-3a50f937e5452c904f583dd60b86c709)

* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000388 "Republic of Estonia"
* status = $100000072049#100000072099  "Valid"

 
* statusDate = "2017-01-10"
* holder = Reference(ORG-100000627)

Instance: auth-for-adace13de52a7dd9afa46fe7ab924022
InstanceOf: PPLRegulatedAuthorization
Title: "Regulated Authorization for COVERAMTablett5mg"
Description: "Regulated Authorization for perindopriil, amlodipiin"
Usage: #example
//* id = "" 
//* identifier.system = $spor-prod
* identifier.value = "584108"
//* identifier.use = #official
// Reference to MedicinalProductDefinition:
//MPD
* subject = Reference(mp-adace13de52a7dd9afa46fe7ab924022)

* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000388 "Republic of Estonia"
* status = $100000072049#100000072099  "Valid"

 
* statusDate = "2008-05-16"
* holder = Reference(ORG-100000964)

Instance: auth-for-da9bd57613b8c0bd0c6e0174c4b7323f
InstanceOf: PPLRegulatedAuthorization
Title: "Regulated Authorization for CO-DALNESSATablett0.625mg, 5mg, 2mg"
Description: "Regulated Authorization for perindopriil, amlodipiin, indapamiid"
Usage: #example
//* id = "" 
//* identifier.system = $spor-prod
* identifier.value = "833013"
//* identifier.use = #official
// Reference to MedicinalProductDefinition:
//MPD
* subject = Reference(mp-da9bd57613b8c0bd0c6e0174c4b7323f)

* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000388 "Republic of Estonia"
* status = $100000072049#100000072099  "Valid"

 
* statusDate = "2013-12-20"
* holder = Reference(ORG-100000627)

Instance: auth-for-938b248e75affacf29383e0738b98ea2
InstanceOf: PPLRegulatedAuthorization
Title: "Regulated Authorization for AMLODIPINE VITABALANSTablett10mg"
Description: "Regulated Authorization for amlodipiin"
Usage: #example
//* id = "" 
//* identifier.system = $spor-prod
* identifier.value = "744411"
//* identifier.use = #official
// Reference to MedicinalProductDefinition:
//MPD
* subject = Reference(mp-938b248e75affacf29383e0738b98ea2)

* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000388 "Republic of Estonia"
* status = $100000072049#100000072099  "Valid"

 
* statusDate = "2011-06-10"
* holder = Reference(MO193)

Instance: auth-for-6a7dda4d31325ba4037a7b5ca32568f2
InstanceOf: PPLRegulatedAuthorization
Title: "Regulated Authorization for WAMLOXÕhukese polümeerikattega tablett160mg, 10mg"
Description: "Regulated Authorization for valsartaan, amlodipiin"
Usage: #example
//* id = "" 
//* identifier.system = $spor-prod
* identifier.value = "903016"
//* identifier.use = #official
// Reference to MedicinalProductDefinition:
//MPD
* subject = Reference(mp-6a7dda4d31325ba4037a7b5ca32568f2)

* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000388 "Republic of Estonia"
* status = $100000072049#100000072099  "Valid"

 
* statusDate = "2016-02-09"
* holder = Reference(ORG-100000627)

Instance: auth-for-87a121d8ef14832e3e60f39822818fec
InstanceOf: PPLRegulatedAuthorization
Title: "Regulated Authorization for CAMDEROTablett5mg, 8mg"
Description: "Regulated Authorization for kandesartaan, amlodipiin"
Usage: #example
//* id = "" 
//* identifier.system = $spor-prod
* identifier.value = "958918"
//* identifier.use = #official
// Reference to MedicinalProductDefinition:
//MPD
* subject = Reference(mp-87a121d8ef14832e3e60f39822818fec)

* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000388 "Republic of Estonia"
* status = $100000072049#100000072099  "Valid"

 
* statusDate = "2018-02-13"
* holder = Reference(ORG-100000627)

Instance: auth-for-3ce5ba0615d73ef5c32173a29faaa66a
InstanceOf: PPLRegulatedAuthorization
Title: "Regulated Authorization for CO-DALNESSATablett4mg, 1.25mg, 10mg"
Description: "Regulated Authorization for perindopriil, amlodipiin, indapamiid"
Usage: #example
//* id = "" 
//* identifier.system = $spor-prod
* identifier.value = "832813"
//* identifier.use = #official
// Reference to MedicinalProductDefinition:
//MPD
* subject = Reference(mp-3ce5ba0615d73ef5c32173a29faaa66a)

* type = $220000000060#220000000061 "Marketing Authorisation"
* region = $100000000002#100000000388 "Republic of Estonia"
* status = $100000072049#100000072099  "Valid"

 
* statusDate = "2013-12-20"
* holder = Reference(ORG-100000627)
